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Multifunctional enzymes catalyzing successive reactions have evolved several 
mechanisms for the transport of intermediates between active sites. One mechanism, 
substrate channeling, allows the transport of the intermediate without releasing it into 
the solvent. Members of the glutamine amidotransferase (GAT) family often utilize 
substrate channeling for the transport of intermediates. GAT enzymes hydrolyze 
glutamine to ammonia, which is transported to an acceptor domain preventing 
wasteful hydrolysis of glutamine and increasing the efficiency of the reaction. Many 
GAT enzymes utilize molecular tunnels to shuttle ammonia between active sites. 
Often GAT enzymes synchronize the active site through conformational changes that 
occur during catalysis.  
Glutamine-dependent NAD synthetases are GAT enzymes and catalyze the 
last step in the biosynthesis of NAD, utilizing nicotinic acid adenine dinucleotide 
(NaAD), ATP and glutamine. Steady-state kinetic characterizations and 
  
stoichiometric analysis of NAD synthetase from Mycobacterium tuberculosis (NAD 
synthetase
TB
) revealed a substrate channeling mechanism for ammonia transport and 
tight coordination of the active sites resulting in an enzyme that is highly efficient in 
the use of glutamine. The crystal structure of NAD synthetase
TB
 has revealed a 40 Å 
tunnel that connects the active sites and is postulated to play a role in the 
synchronized activities. Several regions of the enzyme were identified that may be 
important for regulation, such as the YRE loop which contacts the glutamine active 
site and key regions of the tunnel. Mutations of tunnel residues, such as D656A, show 
that interruption of important interactions can result in compromise in transfer of 
ammonia or active site communication.  
Phylogenetic analysis revealed that glutamine-dependent NAD synthetases 
have different levels of regulation. Three groups of enzymes were identified 
represented by NAD synthetase from M. tuberculosis, S. cerevisiae (NAD 
synthetase
Yeast
) and Thermotoga maritima (NAD synthetase
TM
). Steady-state kinetic 
characterizations and stoichiometric analysis of NAD synthetase
TM 
has revealed a 
compromised coordination of the active sites compared to the highly synchronized 
NAD synthetase
TB
 and the moderate synchronization of NAD synthetase
Yeast
. 
Sequence alignment of these groups has allowed identification of residues that line 
the tunnel that may be responsible for the differences observed in active site 
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Chapter 1: Introduction 
1.1 Multifunctional Enzymes 
In many biosynthetic pathways it is necessary for enzymes to catalyze more 
than one reaction. In these cases the enzyme may contain multiple active sites 
expressed on one polypeptide chain in order to facilitate the reaction (1). These 
multifunctional enzymes catalyze the synthesis of many important biological 
molecules such as amino acids (1-3), nucleotides (4), cofactors (5) and a variety of 
metabolites in the cell. Examples of multifunctional enzymes can be found 
performing a variety of functions. 6-phosphofructose-2 kinase/fructose-2,6-
bisphosphatase is an important enzyme in the regulation of the glycolytic and 
gluconeogenesis pathways and catalyzes two opposing reactions, the breakdown and 
formation of fructose 2,6-bisphosphate that each occur in two separate catalytic 
domains (6). The bifunctional β-lactamase blaLR-13Λ cleaves β-lactams conferring 
antibiotic resistance to the organism. The two domains of the β-lactamase have two 
different specificities toward β-lactam subclasses giving the enzyme a wider substrate 
specificity (1). Many multifunctional enzymes catalyze sequential reactions and it is 
this category of multifunctional enzymes that shall be focused on. There are several 
benefits of multifunctionality including increased coordination of gene function (7, 8) 
and increased kinetic advantage due to the proximity effect (8). Substrate channeling 
(discussed in detail below) is also kinetically advantageous allowing direct transfer of 
intermediates between active sites without diffusion into the solvent. Many 
multifunctional enzymes are also able to regulate catalytic activities through 





1.2 Substrate Channeling 
Enzymes that catalyze multiple reactions have evolved several mechanisms 
for shuttling intermediates between different active sites (Figure 1.1). The first 
mechanism involves the use of a “swinging arm” (Figure 1.1A). In these enzymes a 
prosthetic group is bound to the enzyme on which the substrate is bound. The 
prosthetic groups utilized are biotin, lipoic acid and pantetheine acid (9). The product 
of one active site is then transported where it becomes the substrate for the other 
active sites where it is extended and modified (9). This is exemplified in fatty acid 
and polyketide synthases, both utilize a phosphopantetheinyl group as part of an acyl 
carrier protein to carry the growing molecule to different active sites. Some fatty acid 
and polyketide synthases consist of monofunctional enzyme complexes; however, 
many others are complexes of multifunctional enzymes. Human fatty acid synthase is 
a dimer made up of seven domains per monomer. The type I erythromycin synthase 
contains three multifunctional enzymes performing seven reactions (9). The second 
mechanism involved the physical proximity of active sites in a multienzyme complex 
in which the intermediate would travel a short distance to the next active site (Figure 
1.1B). In some cases formation of these multienzyme complexes have been shown in 
vitro (10). However, as in the case of purine biosynthesis, efforts to show the 
formation of such a multienzyme complex in vitro failed (11). A seminal work (12) 
recently showed that 5-amino-4-imidazolecarboxamide ribonucleotide 
transformylase/inosine 5-monophosphate cyclohydrolase (ATIC), a bifunctional 




formylaminoimidazole-4-carboxamide ribonucleotide intermediate (13), is part of a 
multienzyme complex (the purinosome) with the trifunctional TrifGART and the 
bifunctional PAICS involved in de novo synthesis of purines (12). Low purine 
concentrations in human cancer cells were shown to induce co-localization of these 
enzymes (12). These results are significant because it indicates that multienzyme 
complex formation, and therefore substrate channeling and active site regulation, can 
be regulated by the product of the biosynthetic pathway, in this case by adenosine and 
guanosine nucleotides. It is also suggests that enzymes, which do not form a complex 
in vitro, may do so in vivo in the presence/absence of metabolites. A third mechanism 
involves the transport of a molecule, not covalently bound to the enzyme, between 
distant active sites through an internal “tunnel” (Figure 1.1C) (1, 14). The last 
mechanism involved the diffusion in solution of the intermediate to allow it to reach 
the second active site (10) (Figure 1.1D). After considering the case involving the 
purinosome discussed above it is possible that this mechanism is not used in the cell 
when the intermediate is unstable/toxic or when the intermediate/product formation 





Figure 1.1 The four mechanisms of intermediate transport in multifunctional 
enzymes. A. A substrate is tethered to the enzyme and swings from one active site to 
another where modifications are made or the chain is extended. B. The active sites of 
the enzyme are situated adjacent to each other and the intermediate can pass from one 
active site to another. C. A molecular tunnel allows transport of the intermediate. D. 
An intermediate travels out of one active site, through the solvent to the second active 
site. 
1.3 Enzymes with Molecular Tunnels 
A molecular tunnel allows the passage of the intermediate by connecting two 
active sites that are located on different domains or subunits of an enzyme (15). The 
use of molecular tunnels for the transportation of intermediates has several 
advantages. Prevention of intermediates from release into the solvent increases the 
efficiency of the reaction since no intermediate can diffuse away (16). It protects 




release into the cell (16) such as ammonia, which can be cytotoxic at high 
concentrations. 
Currently enzymes that transfer intermediates through molecular tunnels are 
identified using a variety of techniques. Crystal structures can provide evidence for 
the possibility of a tunnel mechanism. In 1988 the crystal structure of tryptophan 
synthase was solved from Salmonella typhimurium (18). It was determined that the 
two subunits were separated by 25 Å and there existed a tunnel that was large enough 
to allow the passage of the indole intermediate. This was the first large piece of 
evidence for the use of a molecular tunnel to shuttle catalytic intermediates between 
different active sites. Since then a variety of enzymes have been identified that 
contain molecular tunnels utilizing crystal structures, kinetic and biochemical 
techniques. In order to confirm the use of the tunnels identified in crystal structure 
mutagenesis of residues proposed to line these tunnels have been performed in 
attempts to block the tunnel (19-22). Calculating the stoichiometry of product 
formation allows for the indirect determination of transport of an intermediate with in 
an enzyme. A one to one stoichiometry is indicative of transport within an enzyme in 
which the product of one active site is transported and utilized in the second reaction 
and, therefore, no intermediate is lost to solvent. However, if the stoichiometry is not 
one to one a method to determine whether there is some channeling in catalysis is a 
classic isotope dilution experiment, which involves the analysis of the competition 
between the intermediate species labeled with a radioisotope or heavy atom 
introduced into the bulk solvent and the unlabeled intermediate produced by the 








and ammonia hydrolyzed from glutamine compete for incorporation into the final 








NH3 added to the 
bulk solvent then the ammonia formed from glutamine is allowed to equilibrate with 




NH3 can also be dictated by the ratio of the kcat/KM for 
glutamine and ammonia, which is the ratio of ammonia incorporated into NAD 




NH3 is dictated by 
the ratio of the kcat/KM the ammonia produced by glutamine hydrolysis is transported 
within the enzyme and does not equilibrate with ammonia in the solvent (10).  
Enzymes that utilize molecular tunnels to shuttle intermediates catalyze a 
wide variety of reactions that are essential for cellular function. They are involved in 
the biosynthesis of amino acids, nucleic acids and coenzymes such as NAD. There 
are four classes of enzymes with molecular tunnels; enzymes that transport ammonia 
(glutamine amidotransferase) (15), one that transports indole (tryptophan synthase) 
(23), one enzyme that transports carbamate (carbamoyl phosphate synthetase) (24) 
and one that transports carbon monoxide (carbon monoxide dehydrogenase/acetyl-
CoA synthase) (25). Of these four types of enzymes the most numerous are the 
enzymes that transport ammonia that belong to the glutamine amidotransferase 
(GAT) family (discussed below) (14).  
1.4 Glutamine Amidotransferase Family 
Members of the glutamine amidotransferase family contain two domains. The 
first domain is a glutamine amidotransferase domain, which produces ammonia 
through the hydrolysis of glutamine to glutamate. The ammonia is then shuttled to the 




GAT domains hydrolyze glutamine using Cys or Ser residue as a nucleophile (Figure 
1.2). There are four classes of amidotransferases, the triad family, the N-terminal 
glutaminases or Ntn, the amidases and the nitrilase superfamily (26). The triad 
family, also called the class I or G-type, utilizes a Cys-His-Glu catalytic triad and Cys 
acts as a nucleophile to attack the amine of glutamine, examples are carbamoyl 
phosphate synthetase (CPS) and imidazole glycerol phosphate synthase (IGPS). The 
Ntn or class II enzymes do not utilize a catalytic triad but make use of an N-terminal 
cysteine as the nucleophile as is the case with asparagine synthetase B. The amidases 
utilized a nucleophilic serine residue (Figure 1.2 B) and is exemplified by glutamine-
tRNA
gln
 amidotransferase (10). The last class of amidotransferases is the nitrilases, 
which contain a catalytic triad of Glu-Lys-Cys, where Cys acts as a nucleophile, and 
of which glutamine-dependent NAD synthetase is the only member to date. The 
acceptor domains of GAT enzymes do not contain similarities in sequence, structure 





Figure 1.2 The mechanism for glutamine amidotransferase enzymes. A. In the 
class I enzymes a Cys is the nucleophile, Glu acts as the acid/base and His stabilizes 
the negative charge on the transition state. B. In the class II enzymes Cys is the 
nucleophile and there is no catalytic triad. C. In the nitrilases Glu acts as the acid/base 
and Lys stabilizes the negative charge on the transition state. D. The amidases utilize 





Figure 1.3. Examples of reactions catalyzed by the synthase/synthetase domains 
of GAT enzymes. A. The reaction catalyzed by the synthetase domain of carbamoyl 
phosphate synthetase. B. The reaction catalyzed by the synthase domain of imidazole 
glycerol phosphate synthase. C. The reaction catalyzed by the synthetase domain of 
glutamine PRPP amidotransferase. 
 
As mentioned above, many of members of the GAT family utilize molecular 




synthase/ synthetase domain. In the majority of GAT enzymes the molecular tunnels 
are primarily composed of the synthetase domains, therefore, the molecular tunnels 
have few similarities (24). In the majority of these enzymes the ammonia tunnel is 
lined with predominantly hydrophobic residues, such as in asparagine synthetase (27) 
and glutamine phosphoribosylpyrophosphate amidotransferase (GPATase) (28). In 
few examples (glutamine synthase (29), glutamyl-tRNA reductase (30) and the 
thymidylate synthase-dihydrofolate reductase (31)) the tunnel is lined with 
hydrophilic residues. The sequence of the residues that line the tunnels of GAT 
enzymes are strictly conserved in some enzymes, such as GPATase (32), and not 
strictly conserved in others, such as asparagine synthetase (27). In many GAT 
enzymes the ammonia tunnel is fully formed in the enzyme, however, in some cases 
the tunnel is transiently formed during catalysis. The tunnel in glutamine synthetase is 
formed by two cavities that are not connected (29). It is proposed that the residues 
separating the cavities and preventing ammonia passage act as a gating mechanism 
involved in signaling between the active sites (10, 29). The tunnel of both GMP 
synthetase and GPATase are not formed until substrate is bound. In the absence of 
phosphoribosylpyrophosphate (PRPP) no tunnel is observed in GPATase, however, 
the binding of PRPP causes of kink in the C-terminal helix resulting in a restructuring 
of a loop causing formation of ~20 Å long tunnel connecting the active sites (32). The 
crystal structure of E. coli GMP synthetase shows the active sites are separated by 30 
Å but no tunnel was observed (33). However, it is proposed that the binding of the 
substrates, ATP and XMP, causes a major conformational change forming a tunnel 




transport through CPS revealed that ammonia is transported through the tunnel 
through hydrogen bonding interactions between the ammonia molecule and the side 
chains of the residues lining the tunnel (35, 36). The tunnel is sealed from solvent 
(36) and ammonia transport is fast occurring from 9.5 to 14 nsec over a 13 Å portion 
of the tunnel (35). Transport occurs in stages with the ammonia molecule frequently 
oscillating between residues and is favored by a free-energy potential (36). It was also 
shown that the ammonium ion could only proceed partially through the tunnel before 
becoming trapped (35). The tunnel of glucosamine-6-phosphate synthase was also 
analyzed by molecular dynamic simulation also showing fast transport of the 
ammonia molecule (37). It was also revealed that local conformational changes occur 
in the tunnel during ammonia transport (37). A narrow passage was widened through 
the flipping of an Ala sidechain suggesting that this region acted like a gate to the 
next region of the tunnel. Mutagenesis experiments have confirmed the importance of 
many of the residues involved in ammonia transport (36, 37). However, the results of 
these molecular dynamic simulations may not be applicable to ammonia tunnels from 
other enzymes due to the fact that the composition and method of formation of the 
tunnels for GAT enzyme varies a great deal.  
Many GAT enzymes that utilize molecular tunnels synchronize the activities 
of the active sites during the reaction (15, 38) (Table 1.1). The coordination of active 
sites prevents the loss of an ammonia due to diffusion out of the active site into the 
solvent, reaction of the intermediate with the solvent or to conserve a scarce substrate. 
The synchronization of the active sites may occur due to conformational changes in 




34). These can be the result of local changes in the glutamine active site or larger 
conformational changes throughout the enzyme. This coordination of the active sites 
is referred to as active site coupling. This activation of the glutaminase active site due 
to the presence of synthase/synthetase activity occurs in many GAT enzymes (Table 
1.1). The activation can be only a few fold or large. Some examples of of enzymes 
that undergo glutaminase activation are GPATase, IGPS and glutamine synthase. 
GPATase exhibits coupling of the active sites as indicated by the 2.8 fold increase in 
the Vmax of the glutaminase reaction in the presence of PRPP. PRPP binding induces a 
conformational change that modifies the glutaminase active site repositioning an Arg 
residue for glutamine binding and causing a kink in the C-terminal helix which causes 
restructuring of a loop resulting in formation of the ammonia tunnel. (28). IGPS 
undergoes a 4900-fold increase of the kcat of glutaminase activity due to the binding 
of PRFAR, which causes small changes in loops that surround glutamine actives site 
and a conformational change in a partially ordered loop in the synthetase active site 
(15, 42). Glutamine synthase undergoes active site synchronization indicated by the 
22 fold increase in the Vmax of the glutaminase, which occurs through the binding of 
ferredoxin and 2-oxoglutarate (39). It is proposed that glutamine synthase substrate 
binding induces a conformational change in a loop at the glutaminase active site, 
which causes a cascade of changes ending in the formation of a salt bridge and the 







Table 1.1. The activation of the glutaminase activity of several GAT enzymes. 
Enzyme Activation  Mechanism 
CPS 6.5 fold 
(kcat) (17) 
Formation of bicarbonate phosphate triggers 
glutaminase activation (41). 
IGPS 4900 fold 
(kcat) (42) 
PRFAR binding causes small changes in loops that 
surround glutamine actives site and conformational 
change in a partially ordered loop in the synthetase 
active site (15, 42). 
GPATase 2.8 fold 
(Vmax) 
PRPP binding repositions Arg residue in GAT 
active site for glutamine binding and causes a kink 
in the C-terminal helix which causes large 






Ferredoxin and 2-oxoglutarate binding causes a 
conformational change in a glutaminase active site 
loop, activating the N-terminal nucleophilic cys 




69 fold (kcat)  
(44) 
Binding of fructose-6-phosphate causes ordering 
of C-terminal tail then the glutaminase domains 
become ordered (45).   
GMP synthetase  Binding of ATP and XMP forms the ammonia 
tunnel and stimulates catalysis (33). 
Glu-tRNA
Gln






amidotransferase (26) triggers the motion of a hairpin in a adjacent 
subunit which positions a Thr residue for 





The glutaminase and synthase active sites are 
uncoupled and no communication is observed (47). 
 
1.5 NAD Synthetase 
 
Figure 1.4 The reaction catalyzed by the glutaminase and synthetase domains of 
NAD synthetase.  
NAD synthetase catalyzes the last step in the de novo biosynthesis of NAD. It 
is responsible for the formation of nicotinamide adenine dinucleotide (NAD) from 
nicotinic acid adenine dinucleotide (NaAD) and ATP (Figure 1.4). There are two 
forms of NAD
 








), which is 
capable of utilizing glutamine as an ammonia donor. The ammonia dependent 
enzyme is found primarily in prokaryotes, such as E. coli (48) and B. subtilis (49), 




such as Mycobacterium tuberculosis (50) and Thermotoga maritima and the archea 
M. thermophila (Figure 1.5). Recently a glutamine-dependent enzyme was identified 
from Thermus thermophilus that contained both active sites on separate subunits 
(personal communication with Andrei Osterman, Sanford-Burnham Medical 
Research Institute). 
 
Figure 1.5 The types of NAD synthetases. A ammonia-dependent enzyme with only 
the synthetase domain, a glutamine-dependent enzyme with a synthetase and 
glutaminase domain in one subunit and a glutamine dependent enzyme with the 
synthetase and glutaminase domain on separate subunits.  
1.5.1  Ammonia-Dependent NAD Synthetase 
The ammonia-dependent NAD synthetase contains only the synthetase 
domain and utilizes exogenous ammonia as a nitrogen source. The synthetase domain 
is a member of the N-type ATP pyrophosphatases family (51). This family is 
characterized by a flexible nucleotide binding loop designated the P loop. Members 
of this family catalyze reactions that share the ATP-dependent activation of a 




nitrogen nucleophile, in this case ammonia, attacks the acyladenylate intermediate 
releasing AMP (Figure 1.4).  
The crystal structures of ammonia-dependent NAD synthetase from B. subtilis 
(NAD synthetase
Bac
), E. coli (NAD synthetase
Ecoli
), H. pylori (NAD synthetase
HP
) and 
B. anthracis (NAD synthtase
Ban
) has provided a great deal of information about the 
mechanism. NAD synthetase
NH3
 is a homodimer consisting of α-helices and β-sheets 
(52-55). The NaAD binding site is located at the interface of the dimer while the ATP 
binding site is within one subunit (56). The most interesting aspect of the enzyme 
structure is the presence of two flexible loop near the enzyme active site, designated 
loop P1 and P2. In the apo structures both P loops are disordered (41, 44, 45(55). In 
NAD synthetase
Bac
 when only NaAD is bound the P loops are also disordered (52) 
(Figure 1.6A). The P1 loop becomes ordered due to hydrogen bonding of Q84
Bac
 to 
the adenine base of ATP (50, 53, 54). P2 loop stabilization was observed in NAD 
synthetase
Bac
 and NAD synthetase
HP
 (52-54). The ordering of P2 loop involves 
coordination of the Mg
2+





 crystal structures with AMP and pyrophosphate bound contains a 
second magnesium bound and the P2 loop partially ordered. This second active site 
magnesium ion is coordinated to the carbonyl backbone of T208
Bac
 in the P2 loop 
(55-57) (Figure 1.6C). When the NAD synthetase
Bac
 is crystallized with NaAD-AMP 
and pyrophosphate the P2 loop is completely ordered (58, 59) (Figure 1.6B). These 
structures indicate that the binding of ATP and the formation of the intermediate 




loops, when ordered, close over the active site. This ordering of the P loops protects 
the ATP molecule and the unstable NaAD-AMP intermediate from hydrolysis.  
 
Figure 1.6 The ordering of the P2 loop of ammonia-dependent NAD synthetase 
from B. subtilis. A. In the presence of NaAD the P2 loop is disordered. B. In the 
presence of the acyladenylate intermediate the P2 loop is ordered. C. In the presence 
of AMP and pyrophosphate the P2 loop is ordered.  
The ammonia dependent NAD synthetases from several organisms have 
undergone steady state kinetic characterization including those from E. coli, B. 
stearothermophilus, S. typhimurium, B. anthracis and B. subtilis (55, 60-63). NAD 
synthetase has been found to be critical for sporulation and vegetative growth of 
bacteria (61, 64, 65). NAD also plays an important role in many other processes in the 
cell (66) (discussed in chapter 2) This information coupled with the available 
structural data has allowed for ammonia dependent NAD synthetase to become 
targets for the development of inhibitors to combat the rise in antibiotic resistance. 
The first inhibitors developed were tethered dimmers (Figure 1.7), which contained 
hydrophobic groups, a polymethylene linker and a charged nitrogen (67, 68). The 
most effective of these compounds had measured IC50 values as low as 10 to 20 µM 
against NAD synthetase
Bac




inhibitors were suggested to be the result of specific interactions (68). The tethered 
dimmers are bisubstrate inhibitors, which would bind to both the NaAD and ATP 
binding sites. However, the IC50 for the inhibitors are low. This could be because the 
inhibitors are substrate analogs and bind to an open conformation of the enzyme, 
disordered P2 loop, and an ordering of the P2 loop leading to a closed conformation 
may be needed in order to obtain a higher IC50.   
 
Figure 1.7. The first tethered dimer inhibitors of NAD synthetase
NH3
 developed. 
The R groups are aromatic with a charged nitrogen group. From these compound 
libraries were constructed to develop higher affinity inhibitors.  
1.5.2  Glutamine-Dependent NAD synthetases 
The glutamine dependent enzyme contains two domains, the GAT domain and 
the synthetase domain (Figure 1.5). Ammonia-dependent NAD synthetase from B. 
subtilis, while there is low sequence homology (25% homologous to yeast enzyme), it 
is structurally homologous to the synthetase domain of the glutamine-dependent 
enzyme (Chapter 3). The GAT domain is a member of the nitrilase superfamily, 
which catalyze carbon-nitrogen formation or hydrolysis through the attack of a cyano 




E45, K114, C175 to alanine in NAD synthetase from Saccharomyces cerevisiae 
(NAD synthetase
Yeast
) glutaminase specific activity was abolished confirming that 
these three amino acids are essential for glutamine hydrolysis (5). However, ammonia 
dependent activity was also reduced when these residues were mutated. This indicates 
that coupling of the active site may occur due to the fact that modification of the 
glutaminase active site results in changes in the synthetase activity. 
NAD synthetase
Yeast
 was kinetically characterized. The glutaminase activity 
was activated 8 fold in the presence of NaAD. This indicates that there is some 
communication that occurs between the synthetase and glutaminase domain. The 
enzyme also has a 50% channeling efficiency. The channeling efficiency is the 
percentage of ammonia produced by glutamine hydrolysis that proceeds to form NAD 
(Equation 1.1). This percentage gives an indication of whether ammonia is 
transported within an enzyme or is released into solvent. A channeling efficiency of 
100% is indicative of ammonia transport within the enzyme. NAD synthetase
Yeast
, 




When I started to work on this project no crystal structure of any glutamine-
dependent NAD synthetases had been solved. In 2003 Bieganowski et al. performed 
molecular modeling studies that threaded the sequence of NAD synthetase
Yeast
 to the 
nitrilase domain of worm NitFhit (15% identity with yeast enzyme) and the ammonia-
dependent NAD synthetase from B. subtilis (25% identity with yeast enzyme) (5). 






synthetase, however, the low sequence identity between the enzymes 
casted significant doubt on the validity of this model. The model was later shown to 
be incorrect upon determination of the crystal structure of NAD synthetase from M. 




Chapter 2: Kinetic Characterization of NAD Synthetase 
from M. tuberculosis 
2.1 Mycobacterium tuberculosis 
Mycobacterium tuberculosis (M. TB) is the causative bacteria of the disease 
tuberculosis (69). Tuberculosis is spread when an infected individual coughs, 
spraying droplets containing bacteria into the air (69-71). These droplets can hang in 
the air for several minutes and be inhaled by another individual. The droplets enter 
the lungs and can penetrate the alveoli of the respiratory tract (69, 71). The bacteria 
are then engulfed by alveolar macrophages (69-71) (Figure 2.1), white blood cells 
that are involved in non-specific immune response by engulfing cellular debris. Once 
in the macrophage the bacteria are enclosed by phagosomes (70, 71), which are 
vacuoles formed to digest foreign organisms in the cell. There are several possible 
outcomes for the bacteria, hypothetically the phagosome can be activated and fuse 
with lysosomes (an organelle that contains digestive enzymes) leading to bacterial 
death (70, 71). The more accepted hypothesis is the phagosome are not activated and 
the bacteria continue to survive (70, 71). M. TB is capable of changing the 
intercellular conditions inside the phagosome to prevent maturation and fusion with a 
lysosome (70-72). This prevents the acidification of the environment and 
development of an immune response (70-72) allowing for the survival of the bacteria 
for long periods of time in the macrophages now hospitable environment (69-71). 
When the macrophages are lysed other macrophages, lymphocytes and T-cells are 




system of the host is capable of containing the infection. This is referred to as the 
latent or non-active stage in the lifecycle of M. TB in which the bacteria has reduced 
metabolic activity and the host is asymptomatic and not infectious (70, 71). This 
latent period in some cases can last for years (69, 73). When the hosts‟ immune 
system becomes compromised due to illness or age the macrophages are lysed and 
bacteria are spilled into the surrounding tissue and the individuals‟ immune system is 
not able to control the growth of M. TB (70, 71). The surrounding lung tissue is 
destroyed and the host begins showing symptoms of the disease and become 
infectious (70). At this time the bacteria can enter the blood stream and infect 





Figure 2.1 The spread of M. tuberculosis in the lungs. The bacteria enter the lungs 
and are engulfed by alveolar macrophages. Macrophages, lymphocytes and T-cells 
form tubercles to encase the bacteria. Once the cells are lysed the bacteria are capable 
of spreading to other parts of the body. 
Tuberculosis is the leading cause of infectious death globally (69). As of 2002 
it was estimated that 2 billion people were latently infected with the bacteria (69, 73, 
74). An estimated 2 million people die of the disease every year (69, 71) with 9 
million new cases diagnosed (75). Tuberculosis is most devastating in developing 
nations, where 95% of all cases occur (69). In many developing nations tuberculosis 
is the main cause of death and disability. However, in the United States alone an 
estimated 15 million people are infected with M. TB (69). Of the people infected with 




disease in their lifetime (70, 71). The occurrence of HIV has increased the likelihood 
of development of the disease. HIV or infected immunocompromised individuals 
have a 10% chance per year of developing active tuberculosis (71, 74).  
Current treatments for tuberculosis include a six month regimen of 
chemotherapy utilizing a combination of the four first line tuberculosis drugs (69, 70, 
74, 76) (Figure 2.2). Ineffective treatment of the disease due to noncompliance with 
the prescribed drug regimen has resulted in an increase in the occurrence of drug 
resistant tuberculosis (69, 76). Multi-drug resistant tuberculosis is resistant to three of 
the first line tuberculosis drugs (77) and is normally treatable (69, 78, 79). However, 
the treatment regimen involves two years of chemotherapy and in many cases 
resectional surgery (69, 78, 79). It is estimated that approximately 10% of M. TB is 
multi-drug resistant (77). Extreme drug resistant tuberculosis is resistant to all four 
first line tuberculosis drugs and several second line drugs and is often fatal (76-78). 
One high publicized case of drug resistant TB was that of Andrew Speaker who was 
initially believed to be infected with extreme drug resistant tuberculosis and left the 
United States against the regulation of the Center for Disease Control and Prevention 
(80). It was eventually determined that Mr. Speaker was infected with multi-drug 
resistant TB and received eight weeks of treatment before undergoing resection lung 
surgery to remove a tennis ball size of his lung (81). Mr. Speaker continued 
chemotherapy for two years (80, 81). Due to the increase in drug resistance it is 
important to find new drugs for treatment of tuberculosis. All current treatments are 




infection (75). Therefore, new drug targets need to be identified in order to develop 
drugs that are effective against active and latent tuberculosis infection.  
 
Figure 2.2 The four first line drugs for treatment of M. TB infection. 
2.2 Nicotinamide Adenine Dinucleotide 
NAD is utilized as a cofactor for many oxidation/reduction reactions in the 
cell and transfers two electron equivalents (82, 83). NAD cycles between the oxidized 
form of NAD and the reduced form of NADH (84). For example, NAD is the cofactor 
of enzymes involved in electron transport during glycolosis and the citric acid cycle 
for the synthesis of ATP from carbohydrates and fatty acids (83). On top of its role as 
a cofactor NAD is also utilized as a substrate in many biologically important 
reactions (Figure 2.3) such as NAD dependent DNA ligases (84, 85). Recently, it was 
determined that NAD is involved in histone deacetylation reactions, which are 
catalyzed by the yeast proteins Sir2 (86-88) and its mammalian homolog, mSir2α 




H4 histones (84, 86, 87). Sir2 activity has been shown to extend the lifespan of yeast, 
C. elegans and Drosophila cells through maintenance of gene silencing (87, 88). 
NAD also acts as a substrate for ADP-ribosyl transferases (84, 89-92). ADP-ribosyl 
transferase catalyze the transfer of ADP from NAD to modify various cellular 
components such as proteins, nucleic acids and small molecules (84). ADP 
ribosylation of proteins has been shown to be important for a wide variety of 
functions including DNA repair (poly(ADP-ribose) polymerases) (84, 90, 91), 
transcription regulation (91), telomere length (Mono(ADP-ribosyl)transferases) (84), 
calcium efflux (90), protein degradation (91), vesicle trafficking (91) and apoptosis 
(84, 91). An ADP-ribosyl cyclase, CD38, is capable of hydrolyzing NAD to ADP-
ribose as well as cyclizing NAD to form cADPR (cyclic ADP-ribose) (84, 85, 89, 90). 
It has been proposed that the CD38-cADPR system is involved in necrotic beta-cell 
death due to NAD depletion (85). cADPR levels are also associated with mediating 
calcium signals in the cell (90, 92).  
 
Figure 2.3 NAD utilization in the cell. NAD is utilized as a coenzyme and for 




 Besides cADPR other metabolites derived from and involved in NAD 
biosynthesis are also important for cellular function. NaADP has been identified as a 
secondary messenger that modulates calcium in the cells (85, 90, 93). NaADP is 
formed through the base excision reaction performed by CD38 (93) and from NADP 
(83). NaADP is capable of releasing calcium stores in the cells. NaADP was shown to 
be associated with glucose levels in pancreatic β–cells, modulation of membrane 
structure and neurotransmitter release (93). Nicotinamide has been shown to inhibit 
poly(ADP-ribose) polymerases, mono(ADP-ribosyl) transferases and members of the 
Sir2 protein family (89), therefore, regulating NAD utilization. Nicotinic acid has also 
been shown to have a role in modulating levels of lipids in cells (89). 
2.3 NAD Biosynthesis 
NAD biosynthesis is a complex and organism specific biosynthetic pathway, 
which consists of de novo pathways and recycling pathways (94, 95). Depending on 
the organism the precursor of the pathway can differ (94, 95). Prokaryotes utilize L-
aspartate while it was thought that only eukaryotes utilize L-tryptophan (95). 
However, it was recently discovered that some prokaryotic organisms can use 
tryptophan as a precursor as well (96). NAD biosynthesis in Mycobacterium 
tuberculosis proceeds through two pathways, the de novo pathway that proceeds from 
aspartate and the recycling pathway that utilizes nicotinamide/nicotinic acid (97, 98) 
(Figure 2.4). Knocking out nicotinic acid phosphoribosyltransferase activity in the 
recycling pathway or the genes nadA-C in the de novo pathway, leads to viable cells 
showing that neither the de novo nor recycling pathways are essential for NAD 




nicotinic acid to the cells resulted in cell death both for latent and active M. TB (94). 
This indicates that the last two enzymes in the biosynthetic pathway are essential for 
NAD production (Figure 2.4). This is further supported by the inhibition of NAD 
synthetase by indole derivatives showing decrease NAD production (94). Therefore, 
the inhibition of either nicotinic acid mononucleotide adenyltransferase or NAD 
synthetase would result in cell death and these enzymes are good targets for drug 
development.  
 
Figure 2.4 The biosynthetic pathways of NAD formation for Mycobacterium 
tuberculosis and Eukaryotic organisms. 
 The de novo NAD biosynthesis pathway for humans starts from L-tryptophan 
and converges with three recycling pathways at nicotinic acid mononucleotide 
formation (85). Two enzymes catalyze the last step of these pathways, NAD 
synthetase and nicotinic acid/ nicotinamide mononucleotide adenyltransferase (Figure 
2.4) suggesting that NAD synthetase may not be essential for the production of NAD 
in human cells. Therefore, NAD synthetase is a good candidate as a drug target for M. 




NAD synthetases may indicate structural and mechanistic differences that may be 
exploited for M. TB specific inhibitors. 
2.4 Goals of Study 
The long term goal of this study is to develop inhibitors for NAD synthetase
TB
 
that could be developed into drugs for the treatment of M. TB. My project specifically 
focused on structural and kinetic characterization of NAD synthetase
TB
. The 
information here presented is being used by Prof. Gerratana and by our collaborator, 
Prof. Cynthia Dowd (Dept. of Chemistry, George Washington University) to design 
mechanistic-based and structural-based inhibitors. 
2.5 Cloning and Purification 
A previous expression and purification protocol of NAD synthetase
TB
 by the 
Riccardi group involved the use of fusion glutathione-S-transferase and His6 tags in 
order to increase protein solubility (49). However, these protocols did not involve the 
removal of the fusion tags (49). Studies in which the fusion tag was removed resulted 
in low yield of enzyme (approximately 1 mg per 4 L culture) (99). It was speculated 
that the protein was forming inclusion bodies. One construct that utilized a 
thioredoxin tag to aid in solubility resulted in a yield of 9 mg per 2 L of culture (99). 
However, the fusion tag was removed by thrombin proteolysis at room temperature 
for 72 hrs. This proteolytic condition is undesirable due to the fact that proteins are 
often temperature sensitive (100). Therefore, I tried several expression systems with 




complete removal of the fusion tag under conditions that would result in optimal 
protein stability (proteolysis at 4 ºC for several hours) and with a reasonable yield. 
I cloned the gene for NAD synthetase from the genomic DNA of M. 
tuberculosis into several plasmids allowing the expression of the protein in E. coli 
(Figure 2.5). The pG58 expression vector resulted with the enzyme expressed with 
proR8FKAM tag (101), which is a subtilisin protein tag with a self cleavable tag 
induced with fluoride. However, the purification resulted in a low yield of 2.3 mg/L 
culture (0.574 mg/g wet cells) due to inefficient cleavage of the fusion tag. Therefore, 
other vectors were constructed that allows the expression in E. coli of a recombinant 
protein with an affinity tag either at the C- or N-terminus that could be removed by 
the TEV protease (102). The pET28b vector allowed expression of enzyme with His6-
tag modified with a TEV protease site (Figure 2.5). The enzyme was purified by 
nickel column and the fusion tag cleaved by TEV protease. However, the proteolysis 
was not complete; this may have been due to the oligomeric state of the protein 
preventing the exposure of the TEV protease site. Studies of the yeast NAD 
synthetase have shown that it is an oligomeric protein suggesting that NAD 
synthetase
TB
 is also an oligomer and further confirmed by the quaternary structure 
study as shown below (103). A yield of only 4 mg/L culture (1 mg/g wet cells) was 
obtained. To increase solubility of the enzyme and, therefore, the yield a construct 
expressing a larger fusion tag was employed (Figure 2.5). The pET32a expressed 
protein with a thioredoxin tag modified with a TEV protease site (Figure 2.5) resulted 
in a yield of only 1.4 mg/L culture (0.35 mg/g wet cells). The pET44a expressed the 




1.2 mg impure protein/L culture (0.3 mg/g wet cells). Due to the fact that cleavage of 
the fusion tag appeared to be affecting the yield of the purifications a native protein 
expression was attempted. A combination of ammonium sulfate and streptomycin 
sulfate precipitation was performed in combination with anion exchange, 
hydrophobic and Blue Sepharose affinity column chromatography. None of these 
techniques resulted in pure protein. The difficulty in the native purification probably 
arises from the low expression of the protein. The previous expression systems were 
abandoned in favor of the SUMO expression system (104) (Figure 2.5). The presence 
of the SUMO tag increased the solubility of glutamine-dependent NAD synthetase, 
but its major advantage was the facile and fast removal of the SUMO tag at 4 °C 
leaving the recombinant protein with only one additional serine at the N-terminus 
(104). This facile removal of the tag in cases when the protease site is not particularly 
accessible is likely due to the fact that the surface of interaction between the Ulp1 
protease and the SUMO tag is extensive (104). 
 
Figure 2.5 The protein expression systems utilized for the expression and 
purification of NAD synthetase
TB
. Expression plasmids for the vectors nadE/pG58, 
nadE/pET41a, nadE/pET32a, nadE/pET44a, nadE/pET28b and nadE/pSMT3 and the 




The expression, purification of the SUMO-tagged NAD synthetase
TB
 and 
removal of the tag were achieved without complications. The enzyme was induced by 
lactose and expressed for 48 hrs at 20 ºC. The protein was purified by nickel column 
and the fusion tag removed by Ulp1 proteolysis. The fusion tag and Ulp1 was 
separated from the protein by a second nickel column followed by gel filtration. The 
subsequent gel filtration step is absolutely required not necessarily for the removal of 
impurities but to separate the enzyme from high molecular weight aggregate protein. 
These aggregate proteins have only 50% of the specific activity of the homogenous 
enzyme (420 ± 11 mU/mg homogenous enzyme, 216 ± 32 mU/mg aggregate 
enzyme). The formation of the aggregate protein maybe due to incorrect folding 
during protein expression because no aggregate peak is observed when the purified 
and concentrated protein is reloaded on the gel filtration column. This procedure 
resulted in a yield of approximately 12 mg of protein from 1 L culture (3 mg/ g wet 
cells) and a purity of over 90% (Figure 2.6). 
 
Figure 2.6 The purification gel of NAD synthetase
TB
 (expected molecular weight 
is 74.682 KDa). Lane 1. Molecular weight ladder. Lane 2. Cells before induction. 
Lane 3. Cells after induction. Lane 4. After cell lysis. Lane 5. After first nickel 




2.6 Quaternary Structural Characterization 
 A previous study has shown that NAD synthetase from Saccharomyces 
cerevisiae is an octamer with a total molecular weight of 600 KDa (103). This was 
determined utilizing native polyacrylamide gel electrophoresis (PAGE). Native 
PAGE is not the most accurate method of determining the molecular weight of a 
protein (105). Proteins will have different charges and shapes as well as molecular 
weight; therefore, they will run on the native PAGE according to these three factors. 
The pre-eminent method for the determination of the quaternary structure is 
ultracentrifugation methods such as sedimentation equilibrium, however, the 
instability of the protein results in precipitation which does not allow for the use of 
ultracentrifugation (105, 106). Another method for the determination of quaternary 
structure is light scattering, however, this requires instrumentation that was not easily 
accessible (105, 107). However, a simple method for quaternary structural 
determination which was utilized is gel filtration which removes the protein charge as 
a variable and can be performed on available instrumentation (105).  
The total molecular weight was determined for NAD synthetase
TB
 to be 548 
KDa (74.682 KDa per subunit) (Figure 2.7). This would make the protein between an 
heptamer and an octamer. These data along with the previous characterization data 
has led to the conclusion that NAD synthetase
TB
 is an octamer, which is confirmed by 





Figure 2.7 The chromatograph of the quaternary structure determination of 
NAD synthetase
TB
. The quaternary structure was determined by gel filtration using 
Sepharose CL-6B resin. Blue Dextran was used to determine the void volume of the 
column. The molecular weight of Thyroglubin is 689 KDa (Kav = 0.10), Ferritin is 
382 KDa (Kav = 0.17), Catalase is 206 KDa (Kav = 0.29), Aldolase is 177 KDa (Kav = 
0.30). The total molecular weight of NAD Synthetase
TB
 was calculated to be 548 
KDa (Kav = 0.13 shown in red). 
2.7 Assay Development 
In order to design drugs against NAD synthetase
TB
 a full characterization of 
the enzyme needed to be under taken. This required the development of enzymatic 
assays in order to kinetically characterize the enzyme. There are several different 
assay methods that can be utilized to monitor the progression of an enzymatic 
reaction. An assay can be continuous direct in which the product or substrate being 




fluorescence ect.) and quantified. In a continuous indirect assay the disappearance of 
a substrate or formation of a product can be coupled with another reaction that will 
produce a product that can be easily detected. The coupled assays can be monitored 
continuously or discontinuously. In a continuous assay the substrate or product 
disappearance or formation can be monitored over time. With a discontinuous assay 
the coupled reaction is not compatible with the reaction conditions of the enzyme and, 
therefore, the enzymatic reaction of interest must be quenched before the coupled 
reaction can be performed. The disadvantage of a discontinuous assay is that they can 
be time consuming and requires more enzyme. Also a proper quench method must be 
determined.  
 A method for quenching the reaction of NAD synthetase was devised due to 
the fact that many of the assays utilized are discontinuous indirect assays. Previous 
quenching procedures involved boiling the enzyme for 1 min and adding 
pyrophosphate as an inhibitor (99). This procedure takes too much time and 
incomplete inactivation resulting in a high error and involves addition of one of the 
products that is to be monitored. Acids such as trichloroacetic acid and HCl were 
tried as well as coupling the precipitation by the acids with chloroform to remove the 
enzyme from the solution. In order to determine if the quenches were effective the 
substrate for the NAD synthetase reaction were combined with the quenching reagent, 
then enzyme was added. The quenched reaction was then incubated at 37 ºC and 
product formation monitored by HPLC. It was found that the concentration of acid 
utilized did not quench the reaction and resulted in degradation of the products. The 




confirmed by HPLC. Low temperatures decrease the speed of the reaction and the 
EDTA removes magnesium from the solution stopping the reaction almost instantly.  
NAD Assays. NAD formation can be monitored by coupling to the reaction catalyzed 
by alcohol dehydrogenase after quenching of the NAD synthetase reaction. Alcohol 
dehydrogenase catalyzes the reversible reaction of ethanol and NAD forming 
acetaldehyde and NADH (Figure 2.8). The alcohol dehydrogenase assay was 
performed as a discontinuous assay because it was suspected that NADH would 
inhibit NAD synthetase activity due the similarity in structure of NADH to NaAD 
and NAD and could theoretically bind to the NaAD/NAD binding site. This was 
confirmed by the inhibition studies discussed below. In order to shift the equilibrium 
toward NADH formation the reaction is performed at pH 8.8 in the presence of an 
excess of ethanol and semicarbazide (108). The semicarbazide traps the acetaldehyde 
to form a semicarbazone sifting the equilibrium to the formation of NADH (109). The 
formation of NADH is then monitored at 340 nm and the amount of NAD that was 
present in the reaction can be directly quantified from the amount of NADH. The 
disadvantage of this assay is that it is a discontinuous assay with a long incubation 
time (45 mins) for the coupling reaction and the reaction was only sensitive down to 
the high micromolar range requiring large amounts of enzyme to be utilized (~0.1 µM 
enzyme per reaction). Therefore, an enzyme cycling assay was adapted (110) to 
overcome the sensitivity issues of the alcohol dehydrogenase assay. The assay 
couples the formation of NAD with lactate dehydrogenase and diaphorase (Figure 
2.8). Lactate dehydrogenase utilizes lactate and NAD to form pyruvate and NADH 




is monitored at 450 nm through construction of a calibration curve for NAD 
concentration (111). This allows the amplification of the NAD signal. Therefore, the 
cycling assay is 200 times more sensitive than the alcohol dehydrogenase assay 
allowing for less enzyme to be used (~0.5 nM enzyme) and for lower error in the 
assay. Also the incubation time for the coupled reaction is 10 mins allowing the 
assays to be faster.    
 
Figure 2.8 The coupling assays for NAD synthetase monitoring NAD formation.  
Glutamate Assay. Glutamate formation by NAD synthetase is coupled to the reaction 
catalyzed by glutamate dehydrogenase. This reaction involves the formation of 
NADH and α–ketoglutarate from NAD and glutamate (Figure 2.9). NADH formation 
is favored due to an excess of NAD and hydrazine and is monitored at 340 nm. The 
quantity of glutamate produced can be determined with the construction of a 
calibration curve of NADH formation verses glutamate concentration (112). One 






Figure 2.9 The coupling assays for NAD synthetase monitoring glutamine 
formation.  
Pyrophosphate/Inorganic Phosphate Assay. Quantifying the production of the 
product AMP can be performed by monitoring the formation of pyrophosphate or 
inorganic phosphate. The formation of inorganic phosphate is assayed with the dye 
malachite green. Malachite green forms a complex with inorganic phosphate 
changing the spectral properties of the solution (Figure 2.10). The amount of 
inorganic phosphate is quantified through the construction of a calibration curve 
relating the change in absorbance at 630 nm with inorganic phosphate concentration 
(113). Pyrophosphate can be quantified by converting the pyrophosphate to inorganic 
phosphate through the use of inorganic pyrophosphatase, which hydrolyzes 
pyrophosphate to inorganic phosphate (114). The inorganic phosphate can then be 
quantified as discussed above. The error for the malachite green assay was high due 
to the instability of the phosphate/dye complex which changed over time resulting in 
variations in the absorbance measured. Also with the addition of the inorganic 
pyrophosphatase the added steps involve increases the error in the assay. A direct 
assay for inorganic pyrophosphate utilizes Phosphate Sensor (Invitrogen). The 
phosphate sensor assay involved the use of the mutant E. coli phosphate binding 
protein labeled with fluorophore MDCC (115, 116). The fluorophore allows for an 




sensitivity in the high nanomolar range as oppose to the alcohol dehydrogenase assay, 
which is sensitive in the micromolar range. The assay can be used as a direct 
continuous assay for the detection of inorganic phosphate allowing the assay to be 
faster than the malachite green assay. For the detection of pyrophosphate the assay 
would be a direct discontinuous assay due the quenching of the NAD synthetase 
reaction and addition of inorganic pyrophosphates. However, the large amounts of 
Phosphate Sensor needed for the assay resulted in the assay being too expensive to 
pursue. For a 450 µl reaction 70 µl (20 µM) of Phosphate Sensor are needed. If five 
concentrations are necessary to obtain a full calibration curve in triplicate then 1050 
µl of Phosphate Sensor would be needed in order to obtain the calibration curve. 
Since each Phosphate Sensor vial is 200 µl at $1495 one calibration curve would cost 
$7848.75. 
 
Figure 2.10 The coupling assays for NAD synthetase monitoring pyrophosphate/ 
inorganic phosphate formation.  
HPLC Assay. NAD and AMP can also be quantified through the use of high 




254 nm and quantifying the peaks based on calibration curves performed with an 
internal standard (Figure 2.11). Two HPLC methods were employed, reverse phase 
HPLC was used to separate NaAD and NaAD analogs while ion-paired HPLC was 
utilized for the separation of AMP, ADP and ATP (117). However, each time point in 
the assay requires an HPLC run that is approximately 40 mins. Also the low 
resolution of the product peaks resulted in high error due to the inaccuracy of the 
quantitation of the products. 
 
Figure 2.11 The HPLC chromatograph for the substrates and products of NAD 
synthetase monitored at 254 nm. An ion-paired analytical Alltech Alltima C18 
column (5 μm, 4.6 x 250 mm) was utilized. Solvent A is 25 mM KH2PO4, pH 6.4, 4 
mM tetrabutylammonium bromide, 5% methanol and solvent B is 25 mM KH2PO4, 
pH 6.4, 4 mM tetrabutylammonium bromide, 50% methanol. The various compounds 
were eluted with a linear gradient from 0-80% in 27 minutes and hold at 80% solvent 




2.8 Order of Substrate Binding: Binding Studies 
 In order to determine the binding order of the synthetase domain substrates the 
binding constants were attempted to be determined. The binding constant of NaAD 
and ATP were determined in the presence and absence of the other substrate. If 
NaAD binds the enzyme after ATP then a decrease in the NaAD Kd may be observed 
in the presence of ATP. Two methods were attempted to determine the binding 
constants of ATP and NaAD, isothermal calorimetry and fluorescent titration.  
 
Figure 2.12 The intrinsic fluorescent titration data for glutamine. Y = Fo-F/Fo-
Fmax. Where Fo is the fluorescence with no ligand, F is fluorescence at a particular 
ligand concentration and Fmax is fluorescence at the maximum ligand concentration. 
The tryptophan fluorescence is quenched as glutamine is added over the course of 30 
mins at room temperature. The glutamine hydrolysis is negligible under these 
conditions. Bi-phasic behavior is seen for the binding of the substrates of NAD 
synthetase M. TB (R
2
 is 0.97). The Kd was 1.3 ± 0.4. Curve fitting attempted to Y= 




Fluorescent titration studies involve the titration of the ligand into the protein 
and the fluorescent signal measured is related to the binding of the protein to the 
ligand. The fluorescence signal can come from a fluorescent ligand or it can be 
intrinsic fluorescence in which the protein contains a tryptophan that will change 
fluorescent properties based upon the change in the exposure to solvent. Both 
methods of obtaining the binding constants through fluorescence were used. For 
tryptophan fluorescence biphasic behavior was seen for all the ligand binding curves 
and fitting to a single bind site curve a poor fit to the data (Figure 2.12). This 
behavior is believed to be due to the presence of 10 tryptophan per monomer in the 
enzyme, therefore interference from the quenching of other tryptophan in the protein 
contribute to the fluorescence decrease. This means that the change in fluorescence is 
not linearly dependent on the binding of the ligand. Instead of relying on the intrinsic 
fluorescence of the protein we then decided to monitor the fluorescence of the NAD 
analog, NADH, which was able to bind to the enzyme and act as an inhibitor (see 
section on inhibition studies). The use of the ligand as the fluorophore has the 
advantage of avoiding the interference of the 10 tryptophan residues in the enzyme. 
However, the disadvantage of this is that larger concentrations of proteins are 
necessary compared to the amount of protein used in intrinsic fluorescence (6 µM 
versus 0.5 µM enzyme) (118-120). Another problem with using the ligand as a 
fluorophore is concentration quenching (121, 122). Above 100 µM NADH 
fluorescence would cause quenching of the fluorescence signal, therefore, at 
concentrations above 100 µM the fluorescent signal would not be linear with the 




mM and assuming that the KM can be utilized as an estimate of the Kd, the 
concentrations of NADH needed to bind NAD synthetase would be above the linear 
region of the NADH fluorescence curve.  
 
Figure 2.13 NADH concentration based fluorescent intensity. The fluorescence is 
linear with NADH concentration to 0.1 mM after which NADH self quenches and 
fluorescence is no longer linear with concentration. The excitation wavelength was 
340 nm. The emission spectrum was monitored at 450 nm. 
Isothermal calorimetry measures the heat release associated with ligand 
binding. The heat release is quantified as ligand is titrated into the protein solution. A 
binding curve is then constructed and the binding constant calculated. This method 
also proved to be unsuccessful due to the large amounts of protein (40 µM enzyme) 
needed for a signal to be detected, stirring at room temperature to diffuse the ligand 




resulted in the enzyme becoming unstable during the course of the experiment (2 hrs) 
and precipitating out of solution. 
2.9 Ordering of Substrate Binding: Inhibition Studies 
Due to the fact that the binding studies proved to be unsuccessful, dead-end 
inhibition studies were performed. A dead-end inhibitor resembles the substrate and 
reversibly binds to the enzyme binding pocket but does not turnover preventing 
product formation (123, 124). Dead-end inhibitors are useful in determination of a 
kinetic mechanism and have the advantage over product inhibitors in that they do not 
cause partial reversal of the enzymatic reaction, therefore, making analysis of the 
inhibition patterns less complex (125). The inhibition constant (KI) can be determined 
for a substrate analog, which is the concentration of inhibitor necessary to obtain half 
maximum inhibition and is an indicator of how potent the inhibitor is. Inhibition 
studies can give information on the order of substrate binding. When there are two 
substrates, A and B, one substrate will be under saturating conditions while the 
concentration of the other substrate is varied at different inhibitor concentrations. The 
data are then plotted on a double reciprocal plot. The slope of the double reciprocal 
plot will be affected if one of two conditions are met: the inhibitor and varied 
substrate bind to the same form of the enzyme or the inhibitor and varied substrate 
bind different forms of the enzyme that are reversibly connected and the varied 
substrate adds after the inhibitor (123, 125). The slope is affected in competitive and 
noncompetitive inhibition plots. The intercept of the double reciprocal plot will be 
affected by addition of inhibitor if the inhibitor and varied substrate add to different 




noncompetitive inhibition plots. The inhibition patterns can then be predicted for a 
random mechanism and ordered mechanisms for enzymes with two substrates binding 
by using two dead-end inhibitors as shown in Figure 2.14 (126).  
 
Figure 2.14 The possible inhibition patterns for an enzyme with two substrates, 
A and B, for an ordered and random mechanism. The dead-end inhibitors are IA, 
which is an analog of A, and IB, which is an analog of B. Below each table is an 
example of a mechanism of substrate binding. In the example for an ordered 
mechanism A binds before B. In the example of the random mechanism A and B bind 
randomly.  
 The analog of ATP, AMPCPP (Figure 2.15), was used as a dead-end inhibitor 
versus the ATP binding site and the NaAD binding site. If AMPCPP was 




uncompetitive then NaAD would bind before ATP (Figure 2.14). The cycling assay 
was used to obtain the inhibition plots (Table 2.1). It was determined that under 
saturating conditions of the other substrate AMPCPP was a competitive inhibitor for 
both the ATP and NaAD binding sites. This could be due to the inhibitor being able 
to fit in the NaAD binding site when the ATP binding site is saturated. Therefore, 
substrate analogs for NaAD, NADH and 3-acetylpyridine adenine dinucleotide 
(acetyl-NAD) (Figure 2.12) were utilized as dead-end inhibitors to determine the 
binding order of the synthetase domain substrates. If one of the NAD analogs was 
noncompetitive versus ATP then ATP would bind after NaAD. If the NAD analog 
was uncompetitive then ATP would bind before NaAD (Figure 2.14). Both NaAD 
analogs are incompatible with the cycling assay. NADH is a product of the cycling 
assay (Figure 2.8). In the absence of NAD synthetase acetyl-NAD causes a high 
absorbance in the cycling assay due to the fact that it is utilized by lactate 
dehydrogenase as a substrate. Therefore, HPLC was utilized to monitor the formation 
of NAD (Table 2.1). However, it was also shown that both NaAD analogs were 
competitive inhibitors for the NaAD and ATP binding sites. All three substrate 
analogs contain ADP moieties which can easily fit in the AMP binding pocket of both 
the ATP and NaAD binding sites. The NaAD analogs are larger than ATP so it was 
assumed that they would not fit in the ATP binding sit. However, the ADP moiety is 
able to bind while the rest of the molecule is outside the binding pocket, which was 
confirmed when the crystal structure was obtained revealing an open ATP/NaAD 
binding pocket (see Chapter 3). This results in an inability to determine the binding 




made to determine the inhibition constants for glutamine analogs such as glutamic 
acid 5-methyl ester, ornithine and asparagine and the product glutamate for utilization 
in crystallographic trials. The inhibition assays contained saturating NaAD and ATP 
while varying glutamine concentration. No inhibition was observed for the any of the 
analogs up to 20 mM indicating that the enzyme has very little or no affinity for these 
glutamine analogs. This behavior is also seen in GMP synthase which, despite a fully 
formed glutaminase active site, does not bind glutamate (33).  
Table 2.1 Inhibitor constants for the substrate analogs. 
Inhibitor KI (mM) 
AMPCPP 0.7 ± 0.1 
NADH 0.11 ± 0.05 
Acetyl-NAD 1 ± 0.7 
The enzyme activity was measured in 10 mM MgCl2, 1 
mM DTT and 50 mM Tris-HCl, pH 8.3 at 37 C. The 
concentrations of ATP and NaAD, 4 and 3 when held 
constant. The concentrations for AMPCPP, NADH and 
Acetyl-NAD were 0 - 4 mM, 0.05 - 4 mM and 0 – 2 
mM respectively. 
 
2.10 Kinetics Analysis Shows Optimal Kinetics Synergism 
We measured the steady-state rate constants for the NAD synthetase
TB
 
catalyzed reactions using exogenous ammonia or glutamine (Table 2.2). Each 
reaction was performed in triplicate and the standard deviation of the error is shown. 
The turnover number for the reaction using ammonia is at least five- to six-fold faster 
than for the reaction with glutamine. This does not adjust for the difference in ionic 
strength which decreases the rate of the glutamine dependent reaction by 10%. A rate-




account for this difference. The steady-state kinetics data support a mechanism of 
catalysis driven by kinetic synergism. If the KM values can be considered an 
approximation of the Kd then decreases in the KM values of 5- and 12-fold for NaAD 
and ATP, respectively, when glutamine is the nitrogen source instead of exogenous 
ammonia suggest that glutamine binding enhances the affinity of the synthetase active 
site for its substrates. The KM values for glutamine did not change in the presence or 
absence of NaAD and ATP. A 179-fold increase in the glutaminase turnover number 
measured for the reaction in the presence of both synthetase substrates compared to 
their absence indicates a mechanism of activation of the glutaminase domain 
triggered by changes occurring at the synthetase domain. The kcat values for 
glutamine hydrolysis in the presence of only one of the synthetase substrates are 
identical to the value measured in the absence of synthetase substrates, indicating that 






























NAD NaAD Gln, ATP 0.13 ± 0.02 0.50 ± 0.02 3.8 ± 0.6 
NAD ATP Gln, NaAD 0.12 ± 0.03 0.60 ± 0.03 5.0 ± 1.0 
NAD Gln NaAD, ATP 1.3 ± 0.1 0.55 ± 0.01 0.42 ± 0.03 
Glu Gln NaAD, ATP 1.5 ± 0.3 0.68 ± 0.03 0.4 ± 0.1 
Glu Gln None 1.3 ± 0.4 0.0038 ± 0.0002 0.0029 ± 0.0008 

















NAD NaAD NH3, ATP 0.7 ± 0.1 2.6 ± 0.1 3.7 ± 0.5 
NAD ATP NH3, NaAD 1.4 ± 0.2 2.9 ± 0.1 2.1 ± 0.3 
NAD NH3 NaAD, ATP 20 ± 2 3.0 ± 0.1 0.15 ± 0.02 
a
The enzyme activity was measured in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3 at 
37 C. The concentrations of ATP, NaAD, L-glutamine and NH4Cl were 4, 3, 20 and 100 mM, 
respectively, when held constant. Each reaction was performed in triplicate. 
b
These values are 
apparent Km constants at saturating concentrations of the other two substrates. 
Full occupancy of the synthetase domain may be necessary and sufficient for 
the observed activation of the glutaminase domain or it could depend on the 
formation of the NaAD-AMP intermediate or the NaAD-AMP/PPi intermediate 
complex. To distinguish between these possible mechanisms, we tested the ability of 
AMPCPP, a competitive inhibitor of ATP (Table 2.3) (Figure 2.15), to activate the 
glutaminase domain in the presence of NaAD. We did not detect any activation 
(Table 2.3). However, we found that NAD synthetase
TB
 does not catalyze NAD 
formation in the presence of the ATP substrate analog AMPPCP, which contains the 
phosphodiester bond cleaved in the NAD
 
synthetase–catalyzed reaction. The lack of 
AMPPCP activity can be attributed to a nonproductive binding mode of AMPPCP. 




mode that inhibits conformational changes required for glutaminase activity. 
Therefore, we tested the ability of product NAD and analog acetyl-NAD (Figure 
2.15) to activate the glutaminase domain in the presence of ATP, but, again, we 
observed no appreciable increase in activity (Table 2.2). This indicated that binding 
of substrates was not sufficient for activation of the glutaminase domain. Therefore, 
glutaminase activation was triggered by the formation of the acyladenylate 
intermediate or the formation of the acyladenylate/pyrophosphate intermediate 
complex. A non-hydrolyzable acyladenylate intermediate analog was synthesized by 
our collaborator Dr. Clifton E Barry (National Institute of Health, National Institute 
of Allergy and Infectious Diseases, Bethesda, Maryland) in order to mimic the 
intermediate complex (Figure 2.15). The GAT activation of the intermediate complex 
was tested in the presence and absence of 2.5 mM pyrophosphate/Mg
2+
. The 
intermediate analog 1/pyrophosphate/ Mg
2+
 complex showed a 16 fold activation of 
the glutaminase domain (Table 2.3) of the GAT domain. However, intermediate 
analog 1 did not show any inhibition against the enzyme up to 5 mM when ATP or 
NaAD was varied due to the fact that inhibition assays could not be performed in the 
presence of pyrophosphate, which itself is clearly required for binding of inhibitor 1 
based on the inactivation experiment. The moderate activation of the GAT domain 
(16 fold versus 179 fold, Table 2.3) by intermediate analog 1 may be due to the fact 
that limited amount of intermediate analog did not allow saturation to be reached. 
Saturating concentrations of NaAD, AMP, pyrophosphate/Mg
2+
 were utilized as a 
more accurate mimic of the intermediate complex and an activation of 44 fold was 
observed (Table 2.3).  The presence of pyrophosphate and Mg
2+




absolutely required for GAT activation. Taken together, these results indicate that the 
activation of the glutaminase domain is dependent on the formation of the NaAD-
AMP/ pyrophosphate/Mg
2+
 intermediate complex. 
 
Figure 2.15 The effectors of GAT activation. A and B are the analogs of ATP, D is 

















Table 2.3 Activation of the glutaminase domain of NAD synthetase
TB a
 
Effectors Sample Reactions kcat (sec
-1
) Fold activation 
none L-glutamine 0.0038  0.0002 --- 
ATP/Mg
2+
, NaAD L-glutamine 0.68  0.03 179 
AMPCPP/ Mg
2+










0.0003  6E-5 No activation 
NaAD, AMP, PPi/Mg
2+
 L-glutamine 0.167 ± 0.007 44 
PPi/Mg
2+
 L-glutamine 0.002 ± 0.001 No activation 
NaAD, AMP/Mg
2+
 L-glutamine 0.003 ± 0.001 No activation 
Intermediate analog 1 L-glutamine 0.0021 ± 0.0002 No activation 




L-glutamine 0.061 ± 0.004 16 
a
Glutaminase activity was measured in 10 mM MgCl2, 1 mM DTT, 50 mM Tris-HCl, pH 8.3 at 37 
ºC, and with 20 mM L-glutamine. The concentrations of ATP, NaAD, AMPCPP, AMPPCP, Acetyl-
NAD, NAD, Intermediate analog 1 and PPi were 4, 3, 10, 10, 6, 6, 5 and 2.5 mM, respectively. The 
lower limit of detection is 0.0006 sec
-1
 under the conditions of these glutamate assays. 
As discussed in Chapter 1, glutamine-dependent NAD synthetase is a member 
of the GAT family of enzymes. It had been determined that some GAT enzyme 
transport ammonia from one active site to another within the enzyme. A classic 
experiment for the determination of ammonia transport within an enzyme is the 
isotope exchange experiment outlined in Chapter 1. However, a stoichiometric ratio 
of 1:1 = NAD:glutamate produced (Table 2.4) is also indicative of ammonia transport 
within the enzyme due to the fact that a perfect stoichiometric ratio could not be 
achieved if ammonia were released into solvent (see Chapter 1). These data show that 
NAD synthetase
TB
 achieves maximum efficiency at or below physiologically relevant 
concentration of glutamine (4.5 mM) (127) and that the synthetase and glutaminase 
activities are highly synchronized (Figure 2.16). As the glutamine concentration 
increases to 20 mM, the activities of the active sites become partially uncoupled and 





Figure 2.16 The formation of glutamate or NAD production versus glutamine 
concentration. At cellular concentrations of glutamine (~4.5 mM) the channeling 
efficiency is ~100%, as the glutamine concentration increase uncoupling of the 
activities are seen. Curves fitted to kobs = kcat [S] / KM + [S].  
 






2.11 Affect of Glutaminase on Synthetase Domain 
To determine whether the glutaminase domain acts reciprocally to control the 
ammonia-dependent NAD synthesis, we measured the catalytic properties of the 6-
Gln concentration AMP/NAD Glu/ NAD % Channel Efficiency 
1.5 mM n.d 1.05 ± 0.05 95 ± 5 
5.0 mM n.d. 1.12 ± 0.13 89 ± 12 
20.0 mM 0.9 ± 0.2 1.36 ± 0.13 73 ± 10 
a
All reactions were carried out in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 
8.3, at 37 °C and 0.23 M NAD
+
 synthetase. The concentration of ATP and NaAD
+
 were 




diazo-5-oxo-L-norleucine (DON)-modified enzyme and of the C176A variant. DON 
is an analog of glutamine that reacts with nucleophilic cysteine residues. Modifying 
NAD synthetase with DON traps the GAT domain in the γ-glutamylthioester 
intermediate state. The inactivation of NAD synthetase
TB
 by DON was first 
characterized (Figure 2.17). The progress curve was determined by monitoring NAD 
formation in the presence of various concentrations of DON. The assay was an 
indirect continuous assay coupling the formation of NAD with the activity of alcohol 
dehydrogenase. The alcohol dehydrogenase assay can be used continuously because 
the substrates were under saturating conditions, therefore, there would be no 
competitive inhibition due to NADH formation. DON binds to the enzyme with a 
kinact of 0.21 ± 0.02 sec
–1









) were similar 
indicating equal specificity for both glutamine and the irreversible inhibitor. As 
reported in Chapter 1 C176 is a member of the catalytic triad and acts as a 
nucleophile involved in the hydrolysis of glutamine (Figure 1.1). If this assignment is 
correct mutation of C176 to an alanine residue would result in loss of glutaminase 
activity. The C176A variant lacked glutamine-dependent activity but retained 
ammonia-dependent activity (Table 2.5). However, the DON-modified enzyme 
showed only 18% (kcat = 0.48 ± 0.01 s
-1
) of the ammonia-dependent activity of the 
wild type. This decrease in the activity could be attributed to the inhibition of 
conformational changes required for the synthetase activity due to the increased 
rigidity of the DON-modified enzyme and/or to a limited access to the synthetase 




Table 2.5 Steady state kinetic parameters of the C176A NAD 
C176A NAD synthetase
TB















NAD NaAD NH3, ATP 0.65 ± 0.08 3.7 ± 0.1 5.7 ± 0.7 
NAD ATP NH3, NaAD 0.60 ± 0.09 3.0 ± 0.1 5.0 ± 0.8 
NAD NH3 NaAD, ATP 15 ± 2 3.3 ± 0.1 0.22 ± 0.03 
a
The enzyme activity was measured in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3 at 
37 C. The concentrations of ATP, NaAD
+
, L-glutamine and NH3 were 4, 3, 20 and 100 mM, 
respectively, when held constant. 
b
These values are apparent Km constants at saturating 
concentrations of the other two substrates. 
 
Figure 2.17 The inactivation of NAD synthetase
TB
 by DON. Left: The 
mechanism of DON inactivation. Right: The data for the progress curve for DON 
inactivation and the inactivation constants obtained. The progress curves were fitted 
to the equations [P] = [P]∞ (1-e
(-kt)
) and k = kinact [I]/ KI (1 + [S]/Km + [I]/KI) (128, 
129) with Sigma Plot. Where [P] is the concentration of the product, t is the time, k is 
the rate of the progress curve, [I] is the concentration of DON, [S] is the 
concentration of glutamine. The kinact is 0.21 ± 0.02 sec
–1




2.12 Kinetic Mechanism of NAD SynthetaseTB 
 A kinetic mechanism for the enzymatic reaction is proposed based on the 
kinetic data available (Figure 2.18). The decrease in the KM values for the synthetase 
substrates in the glutamine dependent reaction versus the ammonia dependent 
reaction and the fact that the KM for glutamine does not change in the presence of 
NaAD and ATP suggests that glutamine binds the GAT domain first causing an 
increase in the binding affinity toward the substrates of the synthetase domain. It is 
unknown whether NaAD or ATP binds randomly or sequentially. The activation 
studies have shown that formation of the acyladenylate intermediate and 
pyrophosphate in the synthetase domain triggers a conformational change, which 
causes activation of the glutaminase active site resulting in a 179 fold increase in 
activity. The glutamine is hydrolyzed and the DON modification studies suggest that 
the γ-glutamylthioester formation may have some effect on the synthetase domains 
activity. The ammonia produced from the glutamine hydrolysis travels within the 
enzyme through a proposed ammonia tunnel and reacts with the acyladenylate 





Figure 2.18 The kinetic mechanism of NAD synthetase
TB
. The mechanism, based 
on the kinetic data, shows binding of glutamine causing increased affinity for NaAD 
and ATP, acyladenylate intermediate formation causing activation of the GAT 













3.1 Structure of NAD SynthetaseTB 
 The coordination between the synthetase and glutaminase active sites of NAD 
synthetase
TB
 reported in Chapter 2 indicates a high level of communication between 
the two domains. No crystal structure of a glutamine-dependent NAD synthetase was 
available; therefore, the crystal structure of NAD synthetase
TB
 was determined to 
elucidate the interactions that may be involved in active site coupling and determine 
the mode of ammonia transport through the enzyme.  
 My contribution to this chapter included the expression and purification of the 
enzyme for the crystallization trials. The remaining aspects of the structural 
determination were performed by Dr. Gerratana and Dr. LaRonde-LeBlanc. I also 
carried out the cloning, expression, purification and kinetic characterization of the 
variants with the assistance of Andrew Chang (a biochemistry undergraduate 
student). 
3.2 The Quaternary Structure of NAD synthetaseTB 
 The crystal structure of DON-modified NAD synthetase
TB
 was determined at 
2.35 Å resolution bound to 3 mM NaAD. The crystallization conditions were 1.8 M 
ammonium citrate tribasic dihydrate, pH 7.0, 5% glycerol. The crystals contained 




generated by interaction with an adjacent asymmetric unit related by two-fold 
crystallographic symmetry (Figure 3.1). The crystal structure revealed the enzyme to 
be a 600 KDa homooctamer as proposed in Chapter 2. The overall structure of the 
enzyme consists of the core consisting of the glutaminase domains and the synthetase 
domains pointing outward toward the solvent (Figure 3.1). The glutaminase core is 
formed by two stacked rings rotated roughly 50º relative to each other composed of 
four domains. The two rings are held to together by extensive contacts over 1,687 Å
2
; 
however, the glutaminase domains in the same ring have limited interactions with 
only 709 Å
2
 buried surface area per interface per subunit. Each glutaminase domain 
also has extensive contacts with the synthetase domains of two adjacent subunits 
burying 2,002 Å
2
 of surface area per glutaminase domain (Figure 3.1b). However, 
limited contacts occur between the glutaminase and synthetase domains in the same 
monomer resulting in only 918 Å
2
 buried surface area per domain per subunit. The 
glutaminase domains of subunits whose synthetase domains interact do not directly 
interact. The synthetase domains are arranged in four dimers situated around the 
glutaminase core at the corners of a square (Figure 3.1a). The synthetase dimers are 
similar in structure to the dimers of the ammonia-dependent NAD synthetase (Figure 





 which is comparable to the 2,678 Å
2
 of surface area buried in the 
ammonia-dependent NAD synthetase from Bacillus subtilis (48). A superposition of 
the synthetase dimer of NAD synthetase
TB
 and several NAD synthetase
NH3
 reveals a 
high degree of similarity in the structures around the active site (Figure 3.2a and b). 




the same for each NAD synthetase
TB
 subunit as well as in the ammonia-dependent 
enzyme. However, the nicotinic acid ring is conformationally flexible (Figure 3.2c). 
The synthetase domains are inclined toward the plane between two rings, and dimers 
are formed from synthetase domains of subunits from separate rings (Figure 3.1a). 
Thus, the synthetase domains interlock the rings formed by the glutaminase domains. 
As a result of the complex architecture, one subunit contacts five other subunits in the 
octamer (Figure 3.1).  
 
Figure 3.1 Oligomeric assembly of NAD synthetase
TB
. (a) Quaternary structure of 
NAD synthetase
Gln
. Glutaminase domains (G1 to G8) line the central cavity, whereas 
synthetase domains (S1 to S8) are on the outside. Glutaminase domains in the top 
ring are illustrated in ribbon with a transparent surface representation. The subunits 
are color coded as indicated in the model shown to the right. NaAD bound in the 
synthetase active site is shown in CPK. A 90º rotation about the x axis is shown 
below. (b) Surface and ribbon representation of the four subunits in the asymmetric 
unit. The synthetase and glutaminase active sites are indicated by NaAD and DON in 
CPK, respectively. The white arrows indicate the distances of the active site in G5 to 





Figure 3.2 Superposition of the synthetase domain (residues 320-679) with NAD 
synthetase
NH3
 with different ligands. (a) Stereo view of a ribbon representation of 
backbone superposition (r.m.s.d. 1.78 Å for 206 matched residues) of the S1 and S6 
synthetase domain in magenta on the NAD synthetase
NH3
 (PDB code 1IFX) both with 
NaAD bound shown in sticks. Two NaAD molecules bind each dimer of synthetase 
domains, with the binding site located across the dimer interface as in NAD 
synthetase
NH3
. (b) Cartoon representation of the backbone superposition of S1 in 
yellow with NaAD in sticks on the NAD synthetase
NH3
 with NaAD and ATP/Mg
2+
 
(PDB code 1EE1) in blue (r.m.s.d. 1.88 Å for 207 matched residues), and with 
NaAD-AMP and PPi/Mg
2+
 (PDB code 1KQP) in magenta (r.m.s.d. 1.80 Å for 202 
matched residues). (c) Shows the ligands of panel b in the absence of the proteins. 
Ligands are color coded according to the proteins to which they are bound in b. Mg
2+
 




3.3 The Glutaminase Domain and the Glutamine Tunnel 
 The glutaminase domain of NAD synthetase
TB
 is similar in structure to 
PH0642 (PDB 1J31) (130) a nitrilase from Pyrococcus horikoshii according to a 
secondary-structure matching (SSM) database search (Figure 3.3). The SSM database 
compares the three dimensional structure of proteins by matching secondary 
structures and aligning the protein backbone (131). As with the nitrilase the 
glutaminase domain consists of a β-sandwich surrounded by α-helices. Due to the fact 
that the core of NAD synthetase
TB
 is composed of the glutaminase domains 
surrounded by the synthetase domains the glutaminase active site is not exposed to 
solvent as it would be in a monomer. This leads to the question of how the glutamine 
enters the glutaminase active site. Utilizing CAVER analysis and visual inspection a 
33 Å tunnel was identified and proposed to allow the passage of glutamine into the 
glutaminase active site (Figure 3.4). This glutamine tunnel is formed from two 
subunits. The tunnel leading to the glutaminase active site in subunit 5 (G5) is formed 
by non-conserved residues (Figure 3.4) from the glutaminase and synthetase domains 
of subunit 1 (G1 and S1) as well as mostly conserved residues from G5 which make 
up the third of the tunnel near the glutaminase active site. The average radius of the 




             
Figure 3.3 Right: Backbone superposition of G5 and G1 (1-320 residues) in 
green on PH0642 (PDB code 1J31) in blue slate with r.m.s.d. of 1.66 Å for 230 
matched residues per subunit. The proposed catalytic triad (E52-K121-C176) 
and DON are shown in sticks. Left: The superposition of the atoms of the 
glutaminase active sites. The residues of the active site are in different positions in 
NAD synthetase
TB
 then the nitrilase PH0642. *The distance between E52
TB
 and the 
sulfur of C176
TB
 ranges from 4.1 to 3.6 Å. The distance between the K121
TB
 amine 
nitrogen and the methylene carbon ranges from 5.4 to 4.4 Å and the carbonyl oxygen 





Figure 3.4 DON inhibition of the glutaminase domain. Left: Solid surface 
representation of the 33-Å glutamine tunnel. Subunits 1 and 5 are in magenta and 
green, respectively. DON is shown in CPK. The ammonia tunnel is shown in mesh, 
with the first solvent molecule identified in it shown in cyan sphere. Right: Close-up 
view of the glutaminase active site (green sticks) with C176 covalently modified by 
DON (white sticks). In all eight glutaminase domains a C176
TB
-DON adduct was 
observed, confirming the assignment of C176 as the residue that acts as the 
nucleophile in the glutaminase reaction. The first solvent molecule identified in the 
ammonia tunnel is shown in cyan sphere. Because the crystals were grown in 1.8 M 


































Figure 3.5 Sequence alignments by ClustalW of the glutaminase A. and 
synthetase B. domains of NAD synthetase
TB 
with prokaryotic and eukaryotic 
NAD synthetases. Sequence alignments of NAD synthetase
TB
 with the N-terminal 
domain of the putative nitrilase from P. horikoshii (PDB code 1J31) and with B. 
subtilisis NAD synthetase
NH3
 (PDB code IKQP) was obtained by structural alignment 
using Swiss PDB Viewer. Regions lacking electron density in the synthetase domain 
are shown in blue boxes. Amino acid residues are colored according to conservation 




acetobutylicum NP_348407 amino acid sequences are colored coded according to 
conservation to each other and to the M. tuberculosis enzyme. The M. tuberculosis, 
M. leprae NP_302028, M. bovis NP_856111, H. sapiens BAC65148 and S. cerevisiae 
NP_001283796 amino acid sequences are colored according to conservation with 
each other. Red identical, green high similar and blue weak similar. The catalytic 




 was covalently modified with DON, which mimics the γ-
glutamylthioester intermediate (Figure 2.17). The glutaminase domain of NAD 
synthetase is a member of the nitrilase superfamily and contains a catalytic triad 
consisting of Glu-Lys-Cys as discussed in Chapter 1. The DON modification 
occurred at C176
TB
 confirming the cysteine as the nucleophile. The C176
TB
 is located 
in loop rich region of the protein. In the glutaminase active site the C176
TB
-DON 
adduct has a high degree of conformational flexibility as indicated by the multiple 
conformations observed by comparison of the four C176
TB
-DON adducts and the 
high B factor (Figure 3.6). The B factor (temperature factor) describes the mobility of 
an atom around the position specified in the model. Therefore, it can provide 
information on conformational flexibility of a molecule. The α-carboxylate and α-




. The other two 






 is positioned to 
stabilize the negative charge on the γ-glutamylthioester intermediate transition state 
(Figure 3.4 and 3.7) (132). The position of E52
TB
 allows it to abstract a proton from 
C176
TB




molecule is found within 3 Å of all the C176
TB
-DON adducts and the hydroxyl of 
E52
TB
 and, therefore, may interact with these molecules. In comparison of the 
glutaminase active sites of NAD synthetase
TB
 to the active site of PH0642 there is a 






 (Figure 3.3). The distance 
between the K121
TB
 amine nitrogen and the methylene carbon and carbonyl oxygen 
of the DON molecule ranges from 5.4 to 4.4 Å and 5.1 to 3.8 Å, respectively (Figure 
3.3). This is outside the range expected for an interaction (~ 3 Å) to occur between 
K121TB and the negative charge on the γ-glutamylthioester intermediate (Figure 3.7). 
PH0642 was not crystallized in the presence of DON. Therefore, it cannot be 
determined what the distance would be between the Lys residue and the DON 
molecule.  The distance between E52
TB
 and the sulfur of C176
TB
 ranges from 4.1 to 
3.6 Å (Figure 3.3) while the distance between the corresponding residues in PH0642 
ranges from 3.4 to 3.2 Å. Therefore, the Glu of PH0642 is positioned in the active site 
such that the Glu could abstract a hydrogen from Cys.  In the PH0642 enzyme no 
glutaminase activation is necessary; therefore, the conformation of the active site is in 
a conformation optimum for catalysis, the active conformation. It can be proposed 
that glutaminase activation in NAD synthetase
TB
 (Chapter 2) occurs due to a small 










Figure 3.6 Superposition of the proposed catalytic triad (Glu52-Lys121-Cys176), 
of the side chain of the DON adduct and of Glu177-Tyr127 residues of the four 
glutaminase domains in the asymmetric unit. Glu177 and Tyr127 side chains 
interact with the DON adduct side chain. The side chain of the DON adduct has 
slightly different conformation in each subunit and above average B factors. The four 
glutaminase domains superimpose with an average r.m.s.d. of 0.17Å for 319 C‟s. 
 
Figure 3.7 The mechanism of glutamine hydrolysis. A base, proposed to be E52
TB
, 





3.4 The Ammonia Tunnel and NAD SynthetaseTB Mutants 
 
Figure 3.8 The homooctameric structure of NAD synthetase
TB
 with all eight 
intersubunit tunnels. Half of the subunits are shown in transparent surface and are 
color coded as in Figure 2.11a. The remaining subunits (3, 4, 5 and 8) are not shown 
for clarity. The tunnels identified by CAVER were not continuous between the 
glutaminase and synthetase active sites in all subunits and the gap is indicated by *. 
NaAD and DON are shown in CPK. DON (indicated by a wide circle) is buried in the 
glutaminase domain. The black arrows track the CAVER-identified tunnels with 
glutamine reaching the glutaminase active site and ammonia departing from this site 




glutamine and the exit of NAD, respectively, in the representation shown below 
obtained by a 90º rotation. 
 
As discussed in Chapter 1 some members of the GAT family transport 
ammonia through ~ 18 -40 Å molecular tunnels that connect the active sites. The 
glutaminase and synthetase active sites of a single subunit of NAD synthetase
TB
 are 
~55 Å from each other (Figure 3.1) while the closest active sites are ~35 Å apart. 
Utilizing CAVER a second tunnel was identified that extends for 40 Å from the 
closest synthetase and glutaminase active site (Figure 3.8). The two tunnels join 
together to form a 73-Å U-shaped tunnel (Figure 3.8). Focusing on only subunits G5 




 in the 
glutaminase domain to the carboxyl group of NaAD in the synthetase domain and has 
an average radius of 2.0 Å, wide enough for an ammonia molecule (133). The first 
third from the glutaminase active site of this intersubunit ammonia tunnel is lined 
with residues from the glutaminase domain (G5), and the remaining two-thirds is 
lined with residues of the synthetase domain (S1) (Figure 3.8 and Figure 3.6). 
Ammonia could be transferred through a hydrogen-bonding network starting at 
G5
Y58 




 at the G5-S1 interface of the ammonia tunnel (Figure 3.8). 
The residue Y58
TB
 was mutated to an alanine residue. However, the Y58A mutant 
was unstable under optimized storage conditions of 15% glycerol at -80 ºC. This was 
indicated by the complete loss of activity three days after purification (initial kobs of 
0.0210 ± 0.0001 sec
-1
 a day after purification). Attempts to fully characterize the 




activity of the mutant is stable to allow characterization. Y58
TB
 is located in the 
glutaminase active site and the hydroxyl group interacts with the solvent molecule 
positioned there (Figure 3.4). The solvent molecule interacts with E52
TB
 and the 
DON molecule. The hydroxyl group of Y58
TB
 also hydrogen bonds to E132
TB
 (Figure 
3.8). The removal of the tyrosine side chain also results in the removal of possible 
hydrophobic interactions with F130
TB
 and other hydrophobic residues lining the 
tunnel. An Y58F
TB
 mutant can be attempted in order to retain hydrophobic 
interactions and conserve the size of the residue (Van der Waals volume of Tyr is 141 
Å
3
 and Phe is 135 Å
3





Figure 3.9 The ammonia tunnel and the synthetase active site. Subunits 1, 5 and 
6 are in magenta, green and orange, respectively. (a) Solid surface representation 
of the G5-S1 ammonia tunnel. Large black arrows indicate the direction of ammonia 
transfer in this tunnel and the entrance of glutamine in the glutaminase active site 
through the glutamine tunnel (mesh). DON and NaAD are shown in CPK while 
ordered solvent molecules identified are shown in cyan spheres. The two small black 
arrows indicate the hydrophobic constrictions identified in the ammonia tunnel. (b) A 
schematic of the interactions with solvent molecules (cyan spheres) identified in the 




Residues invariant among the prokaryotic glutamine-dependent enzymes are 
indicated by * and those conserved also in the eukaryotic enzymes by **. (c) Fo-Fc 
map contoured at 1.0  of NaAD in a close-up of the synthetase active site. Active 
site residues shown in sticks are colored according to the subunit to which they 
belong. The location of the ATP molecule (transparent sticks) was assigned by 
superposition with the NAD synthetase
NH3
 structure with NaAD and ATP/Mg
2+
 
bound (PDB code 1EE1). Mg
2+
 and an ordered solvent molecule are shown as a 
transparent green sphere and a cyan sphere, respectively. 
As a result of the tunnel's convoluted U shape, one short loop (residues 127–
131, the YRE loop) conserved in mycobacterium and eukaryotes (Figure 3.5 and 3.9) 




) and three different sections of the tunnel 




 forms with two other 
hydrophobic residues the first constriction (0.8 Å) of the ammonia tunnel (Figures 













 are located at the S1-G5 interface in the ammonia 













conserved residues in prokaryotic enzymes, mediate the transition from the G5 to the 









) inhibits activation of the glutaminase domain in the reaction 
with the synthetase substrates, as evidence by the only 9-fold activation of this variant 
compared to the 179-fold activation measured for the wild type (Table 3.1 and 2.3). 













 was significantly compromised, as evidenced by the 
only ~30% maximum channel efficiency of this variant compared to the 100% 
maximum channel efficiency measured in the wild-type catalyzed reaction (Table 
3.2). The D656A
TB
 substitution could have caused a large disruption of the enzyme 
structure resulting in a lower channeling efficiency or the mutation could have 
resulted in small conformational changes disrupting key interactions. In order to 
assure that the structure of the protein was not compromised by the D656A mutation 
the circular dichroism (CD) spectra were obtained for wild type and mutant NAD 
synthetase
TB
. The CD spectra show that there are no large scale differences between 
the structure of wild type enzyme and the D656A mutant (Figure 3.11). It is possible 
that disruption of the interactions at the S1-G5 interface and loop YRE yields an 
enzyme that is markedly wasteful of glutamine and with a substantially compromised 
ability to transfer ammonia between active sites. It would be beneficial to obtain a 
crystal structure of the D656A mutant in order to determine the cause of the 





Figure 3.10 The YRE loop in of the glutaminase domain (G5) of NAD 
synthetase
TB
. The interactions of the YRE loop with K644 and D656 are shown. 
 
















NAD NH3 NaAD, ATP 0.089 ± 0.005 
0.0045 ± 
0.0001 
0.051 ± 0.003 
NAD Gln NaAD, ATP 
7.8 ± 1.4 0.012 ± 0.0007 0.0015 ± 0.0003 
Glu Gln NaAD, ATP 
9.3 ± 1.5 0.048 ± 0.003 0.051 ± 0.0009 
Glu Gln None 
0.1 ± 0.05
 
0.006 ± 0.0003 0.053 ± 0.02
 
a
The enzyme assays were performed in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3, at 37°C. 
b















Figure 3.11 The CD spectra of wild type and mutant NAD synthetase
TB
. The UV 
CD spectra of C176A, D656A, L486A, L486F and wild type NAD synthetase
TB
 was 
acquired from a range of 300 nm to 185 nm at 37 ºC in Na2HPO4/NaH2PO4, pH 8.5. 
The A280 of all the samples were 0.4. The mutant enzymes have similar spectra to the 




Gln concentration AMP/NAD Glu/ NAD % Channel Efficiency 
1.5 mM n.d 1.05 ± 0.05 95 ± 5 
5.0 mM n.d. 1.12 ± 0.13 89 ± 12 




1.5 mM n.d 3.1 ± 0.5 32 ± 5 
5.0 mM n.d. 3.5 ± 0.4 28 ± 3 
20.0 mM n.d. 3.5 ± 0.3 29 ± 3 
a
All reactions were carried out in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3, at 37 
°C and 0.23 M NAD
+
 synthetase. The concentration of ATP and NaAD
+


















 mediates the transition from 
the G5 to the S1 section of the ammonia tunnel (Figure 3.9a, b). Thus, a residue from 
a third subunit, S6, is part of the G5-S1 ammonia tunnel. The R658L mutant was 
unstable and lost all catalytic activity one week after purification (initial kobs one day 
after purification 0.0034 ± 0.0004 sec
-1
). This may have been the result of the loss of 
hydrogen bonding interactions or due to the Leu taking on a different conformation 
then the Arg. The S1 section of the tunnel closer to the glutaminase domain is lined 
with polar residues and contains ordered solvent molecules. The tunnel narrows to 1.0 
















 and void of solvent molecules (Figure 3.9a, b), to resume its hydrophilic 
character near the synthetase active site. The importance of the second hydrophobic 
patch was demonstrated by the mutation of L486
TB
. The L486A variant removed the 
leucine side chain in an attempt to open the hydrophobic constriction (Van der Waals 
volume of Leu is 124 Å
3
 and Ala is 67 Å
3
) (Figure 3.11). The mutant was found to 
have no change in channeling efficiency from wild type (Table 3.5); however, there is 
only a 16-fold activation of the glutaminase domain (Table 3.3). The L486F variant 
was constructed in an attempt to partially block the ammonia tunnel due to the 
increase in Van der Waals volume of Phe (Van der Waals volume of Phe is 135 Å
3
) 
(Figure 3.11). This variant resulted in an enzyme with a slight compromise in 
channeling efficiency (Table 3.5, 73.7% channeling efficiency versus 95%). The 
activation of the glutaminase activity was 24-fold (Table 3.4). These data indicate that 




glutaminase domain the formation of the NaAD-AMP/pyrophosphate intermediate 
complex formation, causing glutaminase activation. The second constriction site may 
also be involved in the regulation of ammonia transport through the tunnel. Slight 
changes in the conformation of the enzyme may occur during catalysis or due to 
breathing of the protein allowing ammonia to pass the second constriction site. If this 
is the case then the introduction of a smaller side chain (L486A) would not affect the 
passage of ammonia, however, the introduction of a larger side chain (L486F) would 
result in a partial blockage of the tunnel and a decrease in channeling efficiency. 
Construction of a L486W mutant may result in a larger blockage of the ammonia 
tunnel (Van der Waals volume of Trp is 163 Å
3
) and would be predicted to cause a 
larger compromise in channeling efficiency. Construction of the L486W mutant is 
under way. This combination of hydrophobic and hydrophilic surfaces of the tunnel 
differs from the ammonia tunnels in all other GAT enzymes, which are either 
uniformly hydrophobic (10, 14, 134, 135) or hydrophilic (133, 134). 
















NAD NH3 NaAD, ATP 
14 ± 3 1.8 ± 0.1 0.13 ± 0.03 
NAD Gln NaAD, ATP 
1.15 ± 0.08 0.67 ± 0.01 0.58 ± 0.05 
Glu Gln NaAD, ATP 
2 ± 0.1 0.94 ± 0.02 0.47 ± 0.03 
Glu Gln None 0.3 ± 0.1 0.058 ± 0.001 0.20 ± 0.06 
a
The enzyme assays were performed in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3, at 37°C. 
b





















NAD NH3 NaAD, ATP 21 ± 3 0.77 ± 0.04 0.036 ± 0.005 
NAD Gln NaAD, ATP 1.13 ± 0.05 0.311 ± 0.003 0.27 ± 0.01 
Glu Gln NaAD, ATP 2.2 ± 0.3 0.55 ± 0.02 0.25 ± 0.04 
Glu Gln None 0.5 ± 0.2 0.023 ± 0.002 0.05 ± 0.02 
a
The enzyme assays were performed in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3, at 37°C. 
b
These values are apparent Km constants at saturating concentration of the other two substrates. 
 








1.5 mM n.d 1.05 ± 0.05 95 ± 5 
5.0 mM n.d. 1.12 ± 0.13 89 ± 12 




1.5 mM n.d 1.08 ± 0.04 92.8 ± 0.03 
5.0 mM n.d. 1.19 ± 0.05 84 ± 3 




1.5 mM n.d 1.36 ± 0.01 73.7 ± 0.01 
5.0 mM n.d. 1.37 ± 0.01 72.8 ± 06 
20.0 mM n.d. 1.70 ± 0.04 58.8 ± 0.2 
a
All reactions were carried out in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3, at 37 
°C and 0.23 M NAD
+
 synthetase. The concentration of ATP and NaAD
+






Figure 3.12 Connecting elements between glutaminase and synthetase active 
sites. Cartoon representation of -helices that connect the synthetase active site to the 
glutaminase active site and the tunnel. Residues involved in interactions between 
elements are labeled. Synthetase domain residues, which form constriction 2 
(indicated by *), and glutaminase domain residues of the YRE loop, which form 
constriction 1 (indicated by *), are shown in yellow sticks. Yellow spheres indicate 
the positions of key hydrophobic residues that bind to NaAD or may sense interaction 
at the end of 17. DON and NaAD are shown in CPK. Ammonia and glutamine 
tunnels are shown in grey solid surface and mesh, respectively.  





, close to NaAD, is positioned to act as a general base for activation 




site for the hydrogen-bonding interaction if ammonia is transferred (Figure 3.9a, b). 
This role was assigned to the D173
Bac
 in NAD synthetases
NH3
 (56). 
An ammonia tunnel was previously identified in a homology model of NAD 
synthetase
yeast
 generated by threading (136). The suggested ammonia tunnel is 
inconsistent with the structure presented here. Using sequence alignment, we 
identified the corresponding residues in the three-dimensional structure of NAD 
synthetase
TB
 to those reported in NAD synthetase
yeast
 (Figure 3.5). Most of the 
residues proposed to line the tunnel for the yeast enzyme are scattered in the crystal 
structure and are located far from active sites and from the ammonia tunnel identified 
by CAVER (Figure 3.13). The only exceptions are Y532
yeast





), which was shown in this structure and in the NAD 
synthetase
NH3




), which is 
located on the same loop as C176
TB
 but faces in the opposite direction from the 




), which lies at the end of α17 helix 





Figure 3.13 Mapping of the mutations of yeast NAD synthetase reported in 
Brenner et al.(137) on S1 and G5 of NAD synthetase
TB
. Residues corresponding to 
those mutated are shown in spheres and colored red (class I), blue (class II), yellow 
(class III), cyan (class IV), and purple (class V) (137). Ammonia and glutamine 
tunnels are shown in grey solid surface and mesh, respectively. 
3.5 The Synthetase Domain of NAD SynthetaseTB 
The synthetase domain of NAD synthetase
TB
 belongs to the N-type ATP 
pyrophosphatase family present in two other GAT enzymes, GMP and asparagine 
synthetases (27, 33). However, the similarity is limited to the ATP binding site, and 
the remaining structural elements among these synthetase domains are substantially 
different (Figure 3.14). The complete active unit consists of a dimer of two synthetase 
domains. Whereas the secondary-structural elements in the NAD synthetase
NH3
, 
including the dimerization interface, are conserved in the synthetase domain, NAD 
synthetase
Gln




for oligomeric assembly (Figure 3.15). Many of the conserved α-helices, most 
notably α9, are offset and/or longer in the synthetase domain of NAD synthetase
TB
 
compared to that of the ammonia-dependent enzyme. The extended N-terminal 
helical segment of α9 (residues 333–339
S1
), which is absent in the NAD 
synthetases
NH3
 (Figure 3.12 and Figure 3.2), contacts the glutamine tunnel. The C 
terminus of α9 is located at the binding site of the 
S6
NaAD molecule in the synthetase 








, which are 
conserved in the prokaryotic NAD synthetases
Gln
 (Figure 3.12 and Figure 3.5). These 




, whose backbone 




 is located on a loop lining the 
tunnel that contains two of the residues that contribute to the constriction (constriction 
2) in the ammonia tunnel near the synthetase active site (Figure 3.12). α9 is a 
connecting structural element that is likely to contribute to regulation of the reactions 
at the synthetase and glutaminase active site. 
 
Figure 3.14 Superposition of the synthetase domains of NAD synthetase
TB
 with 




(r.m.s.d. 3.04 Å for 175 matched residues) of S1 (residues 320-679) in magenta with 
NaAD in sticks on GMP synthetase in cyan with AMP and PPi/Mg
2+ 
 in sticks (PDB 
code 1GPM). (b) Backbone superposition (r.m.s.d. 3.00 Å for 153 matched residues) 
of S1 (residues 320-679) in magenta with NaAD in sticks on asparagine synthetase in 
cyan with AMP in sticks (PDB code 1CT9).  
The synthetase domain contains three regions for which we observed no 
electron density. Region 1 (residues 402–407, equivalent to loop P1 in the ammonia-
dependent enzymes
10
) acts as a lid when ATP is bound in the ATP binding site and is 





 is likely, given the structural similarity of the ATP binding 
sites among NAD synthetases. Region 2 residues 442–450 on the surface of the 
synthetase domain is disordered in half of the synthetase domains in the octamer. 
Ordering in the other subunits is probably due to crystal packing. Region 3 residues 
542–558, corresponding to loop P2 in NAD synthetase
NH3
 is also always disordered 
when the ATP binding site is empty. Loop P2 ordering is probably required to protect 
the NaAD-AMP intermediate from hydrolysis (52). The N terminus of α17 is 
connected to loop P2 in the NAD synthetases
NH3
 and contacts the NaAD biding site 








 (Figure 3.12). At the C 








 from the YRE loop 
in the glutamine tunnel (Figure 3.12). Therefore, α17 is another structural element 
that is likely to contribute to the regulation of catalysis in NAD synthetases
TB
. The N 
terminus of α17 is connected to loop P2 in the NAD synthetases
NH3
, which should 




between NaAD-AMP/pyrophosphate formation and ammonia formation and/or 
access to the tunnel by contacting the YRE loop. Notably, an alanine variant of 
Tyr601
yeast
, which corresponds to Leu566
TB
 near the end of α17 (Figure 3.13), shows 
poor ammonia-dependent synthetase–specific activity (137), probably because of an 
impaired movement of loop P2 in formation of the intermediate. If α17 indeed acts as 
a communication wire between conformational changes at loop P2 and ammonia 
formation, this variant should have a decreased activation of the glutaminase domain 
in the presence of synthetase substrates. Accordingly, the turnover number for the 
glutaminase activity in the presence of the saturating synthetase substrate decreased 
by 40-fold for this variant, whereas the decrease in the basal glutaminase activity was 
only four-fold (137), supporting a compromised glutaminase-activation mechanism. 
Two other elements, α14 and α9, are positioned to transmit information about the 
NaAD binding state, and α14 may also respond to intermediate formation (Figure 
3.12). As a result of its close connection to constriction 2, it induces widening of the 
constriction to allow ammonia to move into the synthetase active site.  
 
Figure 3.15 Cartoon representation of one subunit of NAD synthetase
TB
 shows 




(bound to NaAD), and little intrasubunit domain interaction. The -helices 
(circles) and -strands (squares) are numbered and colored from blue to red from the 








Chapter 4: Comparative Study of Glutamine Dependent 
NAD Synthetases 
4.1 Thermophilic Proteins and Structural Stability 
Life occurs in all regions of the globe including many extreme environments. 
In order to survive cells must adapt to high salt concentrations, extreme pH 
conditions, high pressure and extreme high or low temperatures. Thermophilic 
organisms are capable of optimum growth at high temperatures. Extreme 
thermophiles grow optimally at temperatures above 60 ºC while hyperthermophiles 
grow at temperatures of over 80 ºC (138). Extreme thermophilic organisms belong to 
the domains Archaea and Bacteria while the majority of hyperthermophiles tend to be 
uniquely from the Archaea. Organisms that grow at temperatures of 100-110 ºC are 
exclusively Archaea (139, 140). Thermophilic organisms are often studied because 
the proteins of a thermophilic organism must be thermostable and can be utilized for 
industrial purposes (141). Thermophilic enzymes are the most investigated of the 
extremophilic proteins (139). The most famous example of this type of application is 
Taq polymerase from the extreme thermophile Thermus aquaticus utilized for PCR 
(142). Thermophilic enzymes can be utilized in industrial reactions that need to be 
performed at high temperatures (139). The study of thermophilic enzymes can  also 
give insight into the understanding of protein folding and stability (139). Decreasing 
the flexibility of the enzyme at low temperatures can aid in increasing stability (143). 
This can be achieved by shortening surface loops, increasing the number of prolines 




hydrogen bonds have been shown to contribute 1.3 kcal/mol to protein stabilization 
(145). Increase in hydrogen bonds is seen in the crystal structures of glyceraldehyde-
3-phosphate dehydrogenase from Thermus aquaticus that showed a higher number of 
hydrogen bonds then the mesophilic homologs (144). Increase in ion pairs compared 
to their mesophilic homologs has been seen almost in every hyperthermophilic 
enzyme including O
6
-methylguanine-DNA methyltransferase from Thermococcus 
kodakara, which has four more ion pairs then the homolog form E. coli (144). 
Increasing ion pairs confers thermal stability because of a reduced desolvation 
penalty for the formation of ion pairs at higher temperatures (143). High packing 
density or decreasing solvent exposed surface areas was shown to increase the 
stability of hyperthermophilic aldehyde ferredoxin oxidoreductase compared to the 
mesophilic enzyme by decreasing entropy (144). This is also true for increasing 
subunit contacts that is shown, for example, to increase the thermostability of citrate 
synthases from various thermophilic organisms compared to mesophilic enzymes 
(143). Different thermophilic proteins will utilize several different methods to 
increase thermostability. These structural stabilizing factors are incorporated into 
thermophilic proteins through manipulation of the protein sequence (141). However, 
there is a balance between stability and function because conformational flexibility is 
necessary for catalysis (143). With an increase in stability, function can be 
compromised and an increase in function may decrease structural stability (146). As 
seen with hyperthermophilic RNase from T. kodakaraensis, the enzyme was less 
active when the active site was mutated to increase thermostability. The local 




4.2 Thermotoga maritima 
The organisms of the Thermotogae phylum are rod-shaped, non-spore forming 
bacteria with an outer sheath that envelope the cells referred to as „toga‟ (147). These 
bacteria are isolated from a wide range of environments. The most remarkable 
characteristic of these bacteria is that they are thermophiles with one of the highest 
growing temperatures of bacteria (65-90 ºC) (147). The first bacterium from this 
phylum to undergo extensive study when the genome was sequenced (148) was 
Thermotoga maritima (T. maritima), which was isolated from a geothermal feature 
off Volcano Island, Italy (147).  T. maritima has an optimum growing temperature of 
80 ºC making it a rare bacterial hyperthermophile (140, 148). Another interesting 
aspect of T. maritima is that it is possibly one of the deepest branching lineages of 
Bacteria (148, 149). The genome of T. maritima shows many genes that resemble 
archaeal genes. It was found that 24% of the open reading frames were similar to 
gene from Archaea (148). This is believed to be due to lateral gene transfer between 
the T. maritima and archaeal species (148, 149).  
 The work that I contributed to this chapter was the cloning, expression and 
purification of NAD synthetase from T. maritima and the phylogentic analysis. The 
kinetic experiments were performed by myself and Jason Yaffe (a undergraduate 
biochemistry student). 
4.3 Phylogentic Analysis of Glutamine-Dependent NAD Synthetases 





 (137) have been performed and revealed significant 
differences in the kinetic mechanism. NAD synthetase
TB




catalysis with a 95% channeling efficiency and high synchronization of the active 
sites indicative of an enzyme with an effective regulatory mechanism. NAD 
synthetase
Yeast
 exhibited moderate channeling efficiencies and poor synchronization 
of the synthetase and glutaminase active sites. This raises the question as to whether 
differences in regulation were evolved for different types of organisms. Phylogenetic 
analysis was performed utilizing the sequences of the glutamine-dependent NAD 
synthetases in order to determine if there is a correlation between the evolutionary 
relationship of the NAD synthetase enzymes and the extent and method of regulation.  
Phylogenetic analysis involves the alignment of gene sequences to infer a 
phylogenetic tree. In most methods several phylogenetic trees are calculated and a 
consensus tree is built. The bootstrap is a method to determine the reliability of the 
consensus tree that has been built. This is done by replicating the data, resampling the 
sequence alignments and repeating the analysis. The process is performed a hundred 
or more times and a majority-rule consensus tree is built displaying the bootstrap for 
each branch of the tree showing the percentage of the calculated trees that agrees with 
the consensus tree. There are several methods for building a phylogenetic tree which 
vary in the model used, the number of sequences that can be analyzed and the 
calculation time. The software used to build a phylogenetic tree for glutamine-
dependent NAD synthetases was PHYML using the maximum likelihood method 
(150). This method has been shown to perform best on simulated data and is capable 
of analyzing large numbers of sequences. However, this method is calculation 




The amino acid sequences of 37 glutamine-dependent NAD synthetases were 
utilized in the phylogenetic analysis. Of the NAD synthetase sequences used 26 were 
Bacteria, 10 were Eucarya and 1 was Archaea. The number of Bacteria and Archaea 
sequences used in the analysis was limited by the fact that most bacterial and archaeal 
NAD synthetases are ammonia dependent. Also the calculation intensive maximum 
likelihood method limited the number of sequences due to the length of time of the 
analysis. The phylogenetic tree has a consensus for the majority of the braches over 
50% and only two branches are below 30% (Figure 4.1). Three groups of enzymes 
were identified with sequence similarities below 30%. Group A contains NAD 
synthetase
TB
 as well as various types of Bacteria: pathogenic actinobacteria and 
proteobacteria, plant-symbiotic nitrogen fixing proteobacteria, human associated 
verrucomicrobia, soil proteobacteria and clostridia. The glutamine-dependent NAD 
synthetases in group A are closely related to the enzyme in group B, which contain 
the Eukaryotic enzymes including NAD synthetase
Yeast
. Groups A and B are only 
distantly related to group C, which contain extremophiles such as thermatogae, 
aquificae, deinococcus–thermus and the archaeaon methanomicrobia; photosynthetic 
bacteria such as rhodobacter, chloroflexi, and cyanobacteria; nitrogen fixing and 
nitrifying bacteria such as azobacter and nitrospira. It is important to note that the 
type of tree obtained from this phylogenetic analysis is unrooted. This means that 
there is not time-line information that can be derived and therefore cannot infer the 
evolution of glutamine-dependent NAD synthetase from the tree alone. However, 
evolutionary information can be inferred from the information known about the 




as NAD synthetase from T. maritima (NAD synthetase
TM
) a deep-branching Bacteria. 
Therefore, it is proposed that the members of group C are the ancestral form of 
glutamine-dependent NAD synthetases. This is confirmed by the fact that in group C 
also includes NAD synthetase from T. thermophilus, which codes for two separate 
polypeptide chains with glutaminase and synthetase activities i.e the ancestral form of 
the enzyme before a Rosetta Stone event fused the two subunits together. If the NAD 
synthetases of group C are an ancestral form of the enzyme then it can be proposed 
that the enzymes of this group would be less efficiently regulated the enzymes from 
group A and B. Therefore, NAD synthetase
TM
 was chosen for kinetic analysis were it 






Figure 4.1 The phylogenetic tree for glutamine-dependent NAD synthetase.   
4.4 Cloning, Expression and Purification of NAD SynthetaseTM 
The gene for NAD synthetase, nadE, was cloned from the genomic DNA of T. 
maritima. The gene was digested with BamHI and HindIII then ligated into pSMT3 
vector. The enzyme was expressed in BL21 (DE3) cells and induced with 0.2% 
lactose at 20 ºC for 48 hrs. The purification of the enzyme was performed in the same 
manner as NAD synthetase
TB
 with the exception that none of the buffers contained 
glycerol. It was determined that the inclusion of glycerol in the purification process 
had no effect on the stability of the enzyme as determine by measuring the activity of 
NAD synthetase
TM
 purified with and without glycerol. This is in contrast to what is 




instability. However, during the gel filtration of the NAD synthetase
TM
 the high and 
low molecular weight aggregation peaks were still present with and without glycerol. 
This indicates that incorrect folding occurs during expression for both NAD 
synthetase
TB
 and NAD synthetase
TM
. The protein was stored in -80 ºC with a purity of 
90% (Figure 4.2) and a yield of 8.6 mg enzyme/ L culture (1.72 mg/ g cells).  
 
Figure 4.2 The protein gel of the purification of NAD synthetase
TM
. Lane 1. Cells 
before induction. Lane 2. Cells after induction. Lane 3. After cell lysis. Lane 4. After 
the first nickel column. Lane 5. After the second nickel column. Lane 6. After gel 
filtration. 
4.5 Temperature Dependence of NAD SynthetaseTM 
The kobs for NAD synthetase
TM
 were determined at a temperature range 
between 20 °C and 90 °C (Figure 4.3). The enzyme reaches maximum activity at 
80 °C consistent with the optimum growth temperature for T. maritima. At 
temperature below 65 °C the enzyme shows similar kobs for the ammonia and 
glutamine-dependent reactions (Figure 4.3) and similar substrate specificity for 




temperatures above 65 °C the glutamine-dependent reaction becomes ~20% faster 
than the ammonia-dependent at 80 °C. In contrast, NAD synthetase
TB
 at 37 °C, the 
pathogen optimum growth temperature, is significantly more specific for glutamine 
rather than ammonia at the same pH. 
 
Figure 4.3 The temperature dependent profile of NAD synthetase
TM
. The blue 
line is the ammonia dependent reaction monitoring NAD formation. The red line is 
the glutamine dependent reaction monitoring NAD formation. 
4.6 Steady State Kinetic Characterization of NAD SynthetaseTM 
A full kinetic characterization of NAD synthetase
TM
 was performed in order 
to compare to the mechanism of NAD synthetase
TB
 and that of the previously 
characterized NAD synthetase
Yeast
 (137). Despite the fact that the temperature of 
optimal activity of NAD synthetase
TM
 is 80 ºC all kinetic assay were performed at 37 




yeast. There is a 3 fold decrease in the KM for glutamine in the presence of synthetase 
substrates versus basal glutaminase activity when glutamate production is monitored 
(Table 4.1). The glutamine KM values for NAD synthetase
TB
 and NAD synthetase
Yeast
 
showed no or little effect due to the presence of the synthetase substrates. If one were 
to assume that the KM value was an approximation of the Kd then one could surmise 
that NAD synthetase
TM
 is less specific for glutamine in the presence of NaAD and 
ATP then in the absence. NAD synthetase
TM
 has identical kcat/Km for glutamine and 
ammonia (Table 4.1), which means that the enzyme is not specific for either 
substrate. This is in contrast to what is observed for NAD synthetase
Yeast
 and NAD 
synthetase
TB
 which are specific for glutamine. The kcat value of NAD formation is 16 
fold lower than the kcat value of glutamate formation (Table 4.1). Considering that the 
glutaminase and synthetase activities are mainly uncoupled (discussed below) and the 
lack of activation of the glutaminase domain in NAD synthetase
TM
, the kcat for 
glutamate formation includes only the microscopic rate constants of the hydrolysis of 
glutamine steps (discussed below) while the kcat of NAD formation takes into account 
in addition to the hydrolysis of glutamine steps the transfer of ammonia, the NAD 
synthesis and any conformational change steps. This suggests that a rate limiting step 
occurs after glutamine hydrolysis associated with ammonia transfer to the synthetase 
domain or formation of NAD. However, the kcat value for the ammonia dependent 
reaction is approximately the same as the kcat value for the glutamine dependent 
reaction monitoring NAD formation (Table 4.1), which indicates that the rate limiting 
step is associated with catalytic steps in the synthetase domain or a conformational 




to what is observed with the NAD synthetase
TB
 where the rate limiting step of the 
glutamine dependent reaction is the ammonia transfer, the glutamine hydrolysis or 
any conformational change steps associated with them (see Chapter 2).  
















NAD NaAD Gln, ATP 0.021 ± 0.002 0.160 ± 0.002 7.6 ± 0.7 
NAD ATP Gln, NaAD 0.095 ± 0.008 0.150 ± 0.003 1.6 ± 0.1 
NAD NH3 NaAD, ATP 0.33 ± 0.1  0.24 ± 0.04 0.7 ± 0.3 
NAD Gln NaAD, ATP 0.42 ± 0.05 0.288 ± 0.006 0.68 ± 0.08 
Glu Gln NaAD, ATP 3.0 ± 0.6 4.6 ± 0.2 1.5 ± 0.3 
Glu Gln None 11 ± 2 0.43 ± 0.03 0.04 ± 0.008 
Glu Gln ATP 6 ± 2 1.9 ± 0.2 0.3 ± 0.1 
Glu Gln NaAD 7 ± 2 2.4 ± 0.2 0.3 ± 0.1 
a
The enzyme assays were performed in 10 mM MgCl2, 1 mM DTT and 50 mM Tris-HCl, pH 8.3, at 37°C. 
b
These values are apparent Km constants at saturating concentration of the other two substrates. 
 
 
Figure 4.4 The kinetic scheme for glutamine-dependent NAD synthetase
TM
 
reaction. The NAD synthetase
TM
 reaction monitoring glutamate formation takes into 
account k3 and k-3. The NAD synthetase
TM
 reaction monitoring NAD formation takes 




The activation of the glutaminase domain and channeling efficiencies for 
NAD synthetase
TM 
was monitored at 37 ºC and 80 ºC. A 10 fold glutaminase 
activation was observed at 37 °C (Table 4.1) while at 80 °C only a 2.4 fold activation 
of the glutaminase activity was observed (kobs for the basal glutaminase = 24 ± 2 s
− 1
 
and kobs for the glutaminase with ATP and NaAD
+
 = 60 ± 2 s
− 1
). These values are 
similar to that of NAD synthetase
Yeast
 (8 fold glutaminase activation in the presence 
of NaAD) and far below the activation seen for NAD synthetase
TB
 (179 fold, Table 
2.3). This indicates that for NAD synthetase
TM 
the mechanism of active site 
communication was faulty leading to wasteful glutamine hydrolysis. The activation 
data also show that as in NAD synthetase
Yeast
 the mechanism of communication 
between the two active sites is different from NAD synthetase
TB
. For NAD 
synthetase
TM
 and NAD synthetase
yeast
 glutaminase activity is activated by the 
presence of either ATP or NaAD (Table 4.1) and NaAD, respectively. While for 
NAD synthetase
TB
 the formation of the NaAD-AMP/pyrophosphate intermediate 
complex is necessary to trigger glutaminase activation. As discussed in Chapter 2, the 
channeling efficiency is also indicative of a lack of active site synchronization in the 
NAD synthetase
TM 
catalytic machinery. The channeling efficiency for NAD 
synthetase
TM 
is lower than for NAD synthetase
TB
 and NAD synthetase
yeast
 (Table 4.2). 





Table 4.2 The channeling efficiency of NAD synthetases from T. maritima , M. 
tuberculosis and yeast. 
Concentration Glutamine M. TB TM (37 °C) TM (80 °C) Yeast
a
 
1.5 mM (1.25 mM)
b
 95 ± 5 % 13.9 ± 0.7 % 36 ± 2 % 54 % 
5 mM 89 ± 12 % 9.7 ± 0.1 % 28 ± 3 % 55 % 
20 mM (10 mM)
b
 73 ± 10 % 7.0 ± 0.8 % 19 ± 7 % 51 % 
a
 Data obtained from (137).  
b Concentrations in parentheses apply only to the yeast enzyme. 




 and NAD synthetase
TM
 were 
mechanistically representative of groups A, B and C, respectively, then one could 
draw conclusions about the mechanism of each group of enzymes (Figure 4.5).  The 
members of group A would be the most regulated enzymes with high channeling 
efficiency and activation of the glutaminase domain and, therefore, have high active 
site synchronization. Group B consists of enzymes with moderate channeling 
efficiencies and low glutaminase activation. Group C represents the enzymes that are 
the poorest regulated with low channeling efficiencies and low glutaminase activation 










 and NAD synthetase
TM
 respectively. 
4.7 Structural Studies of Glutamine-Dependent NAD synthetases 
No crystal structure of any other glutamine-dependent NAD synthetase has 
been published except for NAD synthetase
TB
 (see Chapter 3). In the absence of any 
other crystal structure of a glutamine-dependent NAD synthetase the structure of 
NAD synthetase
TB
 can be utilized along with sequence analysis of the glutamine 
dependent NAD synthetases to determine what structural elements are involved in the 





) contacts the DON molecule in the glutaminase active site and 




the glutamine and ammonia tunnel. Phe130
TB
 is part of the first hydrophobic 
constriction in the tunnel and Glu129
TB





mutated to Ala there is a severe compromise in active site communication with a 30 
% channeling efficiency and only a 9 fold glutaminase activation (Chapter 3). The 




, are conserved in groups A and B but is 




 is substituted by Val120
TM
 
removing the potential ionic interaction (Figure 4.6). Phe130
TB
 is conserved also in 
groups A and C but it is not conserved in group B. None of the three residues that 





, chemically conserved and the conserved Pro640
TB
 in A) are conserved in 





Figure 4.6 The amino acid sequence alignment of selected glutamine-dependent 
NAD synthetases. The YRE loop is blocked off in red and Glu129 and Phe130 are 
indicated in green and cyan, respectively. 
In order to verify the role of the residues mentioned above in the regulation 
mechanism and to firmly establish the root of the differences seen in the mechanism 
of regulation of glutamine-dependent NAD synthetases the crystal structures of 
enzymes from group B and C would need to be determined. While the structures of 
the human and yeast enzymes are the subject of Dr. Watchalee Chuenchor‟s and Kati 









conditions. Of these crystallization conditions several were chosen to be optimized by 
varying the pH, salt and cryoprotectant concentrations which produced crystals 
(Figure 4.7). This work is continued by Dr. Watchalee Chuenchor and Kati Chang. 
The next step after attaining crystals would be to utilize the diffractometer to obtain a 
diffraction pattern from the crystal and then analyze the data to obtain a structure. 
 
Figure 4.7 The crystals obtained from crystallization of DON modified NAD 
synthetase
TM
 bound with NaAD. Crystallization conditions Left: 10% PEG8000, 
10% glycerol, 0.085 M HEPES pH 7.5, Right: 8% PEG6000, 15% glycerol, 6% 
MPD, 0.085 M HEPES, pH 7.5. 
4.8 Conclusion 
Taken together the kinetic and sequence analysis indicates that the three 
groups of glutamine-dependent NAD synthetases have different extent of 
communication between active sites. These kinetic differences may be explained by 
any of the differences in single residues discussed or there may be significant 




Therefore, it is important to obtain structural data on enzymes from each group in 








Chapter 5: NaADH Assay Development  
 
5.1 Necessity for the Development of Continuous Direct Assays  
The assays monitoring the formation of the products of NAD synthetase have 
the disadvantage of being discontinuous indirect assays as stated in chapter 2. 
Therefore, a continuous direct assay was to be developed which would decrease the 
time it takes to run the assays and ease the determination of the inhibition of substrate 
and intermediate analogs to be determined. The new assay involves using NaADH as 
a substrate for NAD synthetase to be converted directly to NADH. In order for the 
formation of NADH to be monitored in real time the UV spectra of NaADH and 
NADH would have to be significantly different. It has been shown that NaADPH λmax 
(λmax = ~330 nm) is blue shifted compared to NADPH λmax (λmax = 340 nm) (151). 
Therefore, we reasoned that NaADH and NADH may have a different λmax. If the 
absorbance is taken at the λ of greatest difference between NaADH and NADH then 
it would be possible to monitor the increase in NADH production. After it is 
established that NADH formation can be monitored it needed to be determined if 
NAD synthetase was able to utilize NaADH as a substrate.  
NaAD is needed in order to synthesize NaADH and as a substrate for NAD 
synthetase. The cost of purchasing NaAD has increased over the past five years. 
Sigma-Aldrich is the only supplier of NaAD in the United States and sold 100 mg of 
the sodium salt of NaAD for $169 in 2005 and that price has increased to $230.50 as 
of 2010, a 36% increase in price. More worrisome is a recent 1 year backorder of 




Therefore, it was necessary to develop an alternative method of obtaining NaAD to 
ensure a supply of NaAD if another commercial NaAD shortage occurs. Most 
importantly developing an enzymatic synthesis would allow for the incorporation of a 
radiolabeled atom into the molecule. Utilizing radiolabeled ATP at the formation of 
ribose-5-phosphate or during the last step in the biosynthesis, a P
32
 isotope could be 
introduced into specific regions of NaAD. This would be important for future pre-
steady state kinetic experiments that would require the monitoring of the substrates, 
intermediate and products of the NAD synthetase reaction. An enzymatic synthesis of 
NaAD was modified from the work of Rising and coworkers (152). ATP is the most 
expensive of the starting materials; therefore, ATP recycling reaction was performed 
involving the conversion of AMP to ADP then ATP so that ATP may be conserved. 
The enzymes involved in the biosynthetic reaction were cloned and purified 
(discussed below) with the exception of the ATP recycling enzymes, adenylate kinase 





Figure 5.1 A) The biosynthetic scheme for the synthesis of NaAD. B) The 1, 4 
reduction of NaAD to NaADH. 
5.2 Cloning Expression and Purification of Enzymes Involved in the Biosynthesis 
of NaAD 
Ribose kinase catalyzes the formation of ribose-5-phosphate from ribose and 
ATP (153) (Figure 5.1). The enzyme was expressed from the pBad vector donated 
from Evalena Andersson (Uppsala Universitet, Department of Cell and Molecular 
Biology, Uppsala Sweden) resulting in the enzyme with a N-terminal His6 tag. The 
plasmid was expressed at an OD600 of 0.7 in BL21 (DE3) cells at 37 ºC with 0.2% 
arabinose for 4 hrs. The cells were lysed by French press at 1200 psi in 50 mM Tris 
pH 8.0, 300 mM NaCl, 20 mM imidazole and 1 mM PMSF then centrifuged for 30 




(Qiagen) resin and washed with 50 mM Tris pH 8.0, 300 mM NaCl, 20 mM 
imidazole. The protein was eluted over a gradient of 20 mM to 120 mM imidazole 
over 10 column volumes. The protein was collected and dialyzed in 50 mM Tris pH 
8.0, 300 mM NaCl and 1 mM DTT and stored at -80 ºC. The ribose kinase was over 
95% pure with a yield of 90 mg of enzyme/ L culture (18 mg enzyme/ gram cells). 
The enzyme was active for approximately 1 year under these storage conditions. 
5-Phosphoribosyl-1-pyrophosphate synthetase (PRPP synthetase) converts 
ribose-5-phosphate and ATP to 5-phosphoribosyl-1-pyrophosphate (PRPP) and AMP 
(Figure 5.1). PRPP synthetase was first purified by a native purification modified 
from a procedure previously published (154). The prpp gene was amplified by 
polymerase chain reaction (PCR) from E. coli K12 genomic DNA. The gene was 
digested at the EcoRI and NdeI sites and ligated into pET24a. The gene was 
expressed in BL21 (DE3) cells with 1 mM IPTG at OD600 0.8 at 37 ºC for 12 hrs. The 
cells were lysed by French press at 1200 psi in 50 mM Na2HPO4 pH 7.5, 1 mM DTT 
and 1 mM PMSF and centrifuged for 30 mins at 15,000 rpm. To the cell free extract 
5% ammonium sulfate was added. The pH was adjusted to 7.5 with 1 M NaOH and 
stirred for 30 mins at 4 °C. The precipitation was spun at 15,000 rpm for 30 mins. 
The pellet was resuspended in a minimum amount of 50 mM Na2HPO4 pH 7.5 and 1 
mM DTT. The resuspended pellet was then dialyzed in 2 L of 50 mM Na2HPO4 pH 
7.5, 1 mM DTT and 15 % glycerol for 2 hrs at 4 °C. Glycerol is added to the solution 
to a concentration of 50 % and stored at –20 °C. The yield was 500 mg enzyme/ L of 
culture (100 mg enzyme/ gram cells). It was determined that PRPP synthetase is 




cloudy when purified and required ten times more enzyme in the biosynthesis 
reaction compared to the other enzymes used. The amount of enzyme needed for the 
assay was estimated monitoring the formation NaAD from the starting material by 
ion-paired HPLC (see Chapter 2). The amount of the PRPP synthetase was varied so 
that optimum NaAD production was achieved. It was speculated that the instability of 
the enzyme, which resulted in the cloudiness of the enzyme solution, resulted in low 
enzymatic activity. The use of larger amounts of PRPP synthetase led to the necessity 
of purifying PRPP synthetase frequently while optimizing the NaAD biosynthesis. 
Therefore, a purification method was necessary that would allow for more stable 
enzyme to be obtained and, therefore, higher activity. The enzyme was expressed 
from pET28b with an N-terminal His6 tag donated by Dr. Kwaku Dayie. The enzyme 
was expressed in BL21 A2 cells with 1 mM IPTG at 37 ºC for 12 hours. The cells 
were lysed by French press in 50 mM Na2HPO4 pH 7.5, 1 mM DTT and 1 mM 
PMSF. The protein was stored in 50 % glycerol at -20 ºC. The PRPP synthetase 
(34218 Da) was clear with a yield of 200 mg enzyme/ L of culture (40 mg enzyme/ 
gram cells). While the yield was lower, a third of the amount of enzyme was needed 
to perform the biosynthesis reaction allowing for fewer preparations of the enzyme.  
Nicotinate phosphoribosyltransferase catalyzes the formation of nicotinic acid 
mononucleotide (NaMN) and pyrophosphate from PRPP and nicotinic acid (Figure 
5.1). NAD pyrophosphorylase catalyzes the subsequent formation of NaAD from 
NaMN and ATP. The pncB gene, which codes for nicotinate 
phosphoribosyltransferase, and the nadD gene, coding for NAD pyrophosphorylase, 




were digested with NcoI/ XhoI and NdeI/HindIII respectively. The genes were then 
ligated into pET28b and expressed in BL21 (DE3) cells with 1 mM IPTG at OD600 of 
0.8 and 37 ºC for 12 hrs resulting in a protein with an N-terminal His6 tag. The cells 
were lysed by French press at 1200 psi in 50 mM Tris pH 8.0, 300 mM NaCl, 20 mM 
imidazole and 1 mM DTT then centrifuged for 30 mins at 15,000 rpm. The cell free 
extracts were loaded onto 8 ml Ni NTA agarose (Qiagen) resin and washed with lysis 
buffer. The proteins were eluted over a gradient of 20 mM to 200 mM imidazole over 
10 column volumes. The protein was collected and dialyzed in 50 mM Tris pH 8.0, 
300 mM NaCl and 1 mM DTT and stored at -80 ºC. Both proteins were over 95% 
pure with a yield of 400 mg of enzyme/ L culture (80 mg enzyme/ gram cells) for 
nicotinate phosphoribosyltransferase (45897 Da) and 200 mg of enzyme/ L culture 
(40 mg enzyme/ gram cells) for NAD pyrophosphorylase (24528 Da). Both proteins 
were stable for up to 5 years under these storage conditions. 
5.3 The Biosynthesis of NaAD 
The reaction for the biosynthesis of NaAD contained 12 mM ribose (180 
µmoles), 12 mM ATP (180 µmoles), 24 mM phosphoenolpyruvate (360 µmoles), 24 
mM nicotinic acid (360 µmoles), 100 mM MgCl2 (1.5 mmoles), 5 mM DTT, 50 mM 
KCl, 50 mM K2HPO4 pH 7.2. The reaction was catalyzed by 1 mg 
phosphoribopyrophosphate synthetase, 0.1 mg nicotinic acid 
phosphoribosyltransferase, 0.1 mg nicotinic acid mononucleotide adenylyltransferase, 
2 U adenylate kinase (Sigma) and 4 U pyruvate kinase (Sigma) and was initiated by 
the addition of 0.1 mg ribose kinase for a 15 ml reaction. The reaction was incubated 




more than five hours the yield of NaAD would decrease due to the reversibility of the 
reactions. The yield after five hours is approximately 60 %. Product formation was 
monitored by ion-paired HPLC described in the materials and methods. Once the 
reaction was quenched with 50 mM EDTA the enzymes were removed with an 
Amicon Ultra-15 centrifugal filter unit. Anion exchange chromatography was utilized 
to separate the negative nucleotides. The first resin used was the DE32 resin 
(Whatman) which is based on the diethylaminoethyl (DEAE) tertiary amine 
functional group. A 140 ml (2.5 cm X 20 cm) DE32 column was utilized with various 
gradients of triethylamine bicarbonate buffer pH 6.4 (TEAB buffer). However, there 
was low resolution between the NaAD and AMP peaks. Therefore, the DEAE 
sephadex A-25 resin (Sigma, donated from Dr. Dorothy Beckett) was utilized, which 
also utilizes DEAE in bicarbonate form on a Sephadex scaffold. A 70 ml (2.5 cm X 
10 cm) column was loaded and washed with 700 ml 0.05 M TEAB buffer pH 6.4 and 
a gradient was performed from 0.1 M to 0.4 M TEAB buffer pH 6.4 over 1 L. It was 
found that better resolution of NaAD and AMP was achieved. Nicotinic acid and 
NaMN both eluted with 0.1 M TEAB pH 6.4 while NaAD eluted at 0.2 M and AMP 
eluted at 0.25 M TEAB pH 6.4. This resulted in pure NaAD confirmed by ion-paired 
HPLC. The NaAD triethylamine solution was rotary evaporated with methanol in 
order to facilitate the evaporation of the triethylamine solution. This resulted in a 
brown, sticky solid of NaAD triethylamine salt. In order to exchange the 
triethylamine cation for sodium the NaAD was then passed through an 8 ml (1 cm X 
10 cm) cation exchange column C25 SP Sephadex in Na
+
 form, eluted with water and 




Optimization of the synthesis and purification procedure is necessary in order to 
obtain higher yields of NaAD. Inorganic pyrophosphatase could be added to the 
synthesis reaction in order to prevent reversibility through the conversion of 
pyrophosphate to inorganic phosphate. This would allow the reaction to continue past 
5 hrs resulting in a higher yield of NaAD.  
 
Figure 5.2 The chromatograph of the purifiaction of the NaAD synthesis 
reaction. The column was  a DEAE sephadex A-25 resin. Buffer A was 0.05 M 
TEAB pH 6.4 buffer and buffer B was 1 M TEAB pH 6.5 buffer. 
5.4 Reduction of NaAD 
 For the reduction of NaAD several reducing agents were tried such as sodium 
borohydride, sodium cyanoborohydride and sodium dithionite (sodium hydrosulfite). 
The sodium borohydride and sodium cyanoborohydride reaction did not result in full 




degraded. The sodium dithionite reaction was performed according to a previous 
procedure which results in the specific formation of the 1,4 reduction product (155). 
NaAD is diluted to 30 mM (50 mg, 75 µmoles) in a solution containing 500 mM 
sodium bicarbonate and 500 mM sodium carbonate with a total reaction volume of 
2.5 ml. The solution is bubbled under nitrogen gas in a 5 ml round bottom flask with 
slow stirring at room temperature. After 15 mins under nitrogen 10 equivalents of 
sodium dithionite is added (130.5 mg, 750 µmoles). The solution turns yellow when 
dithionite is added and turns clear again after an hour. The reaction is complete after 3 
hrs. It was found that if the reaction was allowed to continue after 3 hrs then the 
product will be degraded. This reaction results in 100 % conversion of NaAD to 
NaADH with little side reactions (Figure 5.3). The reaction is monitored by ion-
paired HPLC as described above. The formation of NaADH was confirmed by a 
standard NaADH formed from the reduction of NaAD by alcohol dehydrogenase, 
which is capable of utilizing reducing NaAD in a slow reaction over night.  
 
Figure 5.3 The completed reduction of NaAD to NaADH monitored by HPLC. 
The top panel shows the starting material at time 0. The bottom panel shows the 




Several methods for removal of the sodium dithionite were attempted. An 
assay for dithionite was performed in order to determine where dithionite elutes. The 
dithionite test was performed as follows: 20 µl of 100 mM CuSO4 is added to 100 µl 
sample. When at least 10 mM dithionite is present the copper sulfate solution will 
form a dark yellow or brown precipitate (156). A gel filtration P2 resin was first tried. 
It was determined that the sodium dithionite eluted with NaADH causing degradation 
of the product. Therefore, the anion exchange method utilized for the purification of 
the NaAD synthesis product was employed. The reaction was quenched by diluting 
the solution by 100 times and loaded on to 70 ml of the DEAE sephadex A-25 resin. 
The column was washed with 0.05 M TEAB buffer pH 6.4 and NaADH eluted with a 
linear gradient to 0.5 M TEAB buffer pH 6.4. The product was then passed through a 
cation exchange column C25 SP Sephadex in Na
+
 form and lyophilized to obtain 
NaADH sodium salt. 
The UV spectra for both NaADH and NADH were measured at 0.1 mM 
(Figure 5.4). The concentration of NaADH and NADH was determined by measuring 
the absorbance at 260 nm and calculating the concentration using the extinction 
coefficient for NaAD. The extinction coefficient at 260 nm for NaAD and NADH are 
the same therefore it can be assumed that the extinction coefficient at 260 nm for 
NaADH would also be the same as NaAD. The maximum wavelength for NaADH 
(331 nm) is slightly lower than for NADH (340 nm) and the extinction coefficient is 
also lower. Therefore, if one were to monitor a wavelength of 340 nm one would 
expect to see an increase in absorbance as NaADH is converted to NADH. This is 




Utilizing an approximation of the difference in extinction coefficient between NADH 
and NaADH to estimate the lower absorbance limit of the assay, which corresponds 
to 0.016 mM NADH formation, the theoretical detection limit for the assay was 
calculated to be 0.0005 sec
-1
 as calculated in the materials and methods. This is 
approximately the same detection limit calculated for the alcohol dehydrogenase 
(0.0003 sec-1) and glutamate dehydrogenase (0.0006 sec-1) assays.  
 
Figure 5.4 The UV scan of NaADH and NADH at 0.1 mM concentration. The 
maximum wavelength for NADH is 340 nm and for NaADH is 331 nm. The blue line 
is the spectra for NADH. The purple line is the UV spectra for NaADH. The red line 
is the UV spectra for the background. 
 In order to verify that NaADH is a substrate for NAD synthetase NaADH was 
utilized in an enzymatic assay. The enzyme was incubated at 37 ºC with 6 mM 
NaADH, saturating 4 mM ATP, 20 mM glutamine, 10 mM MgCl2, 1 mM DTT and 
50 mM Tris pH 8.3.  The formation of NADH was monitored at 340 nm. However, 




that NADH was not formed in 3 hrs. Therefore, either NaADH is not a substrate for 







Chapter 6: Materials and Methods 
 
6.1 Materials 
 The genes encoding NAD synthetase obtained from M. tuberculosis genomic 
DNA (donated by L.Y. Gao) and from T. maritima MSB8 genomic DNA obtained 
from ATCC 43589D-5. The expression vectors pSMT3 and pUlp1were gifts from Dr. 
C. D. Lima, Sloan Kettering Institute. Ni-NTA agarose resin was obtained from 
Qiagen (Valencia, CA, USA). The Sepharose CL-6B resin and ÄKTA Prime FPLC 
were from Amersham Biosciences (Piscatway, NJ, USA). The Amicon filtration 
apparatus and Ultrafiltration Membranes were from Millipore (Billerica, MA, USA). 
The mass spectra were obtained on a Axima-CFR MALDI-TOF mass spectrometer 
from Shimadzu-Kratos (Nakagyo-ku, Kyoto, Japan). The CD spectra was obtained on 
a J-810 spectrometer from Jasco (Easton, MD, USA).The oligonucleotides were from 
Eurofins MWG Operon (Huntsville, AL, USA) except for the oligonucleotides used 
for the mutagenesis which were from Integrated DNA Technologies (Coralville, IA, 
USA). PCR components and Phosphate Sensor were from Invitrogen (Carlsbad, CA, 
USA). Ligation reagents and restriction enzymes were from Fermentas (Glen Burie 
MD, USA). The crystallization screening kits were obtained from Qiagen (Cryo and 
PEG Suites), Hampton Research (Index) and Emerald BioSystems (Wizard I-II). The 
alcohol dehydrogenase and glutamine dehydrogenase and NAD synthetase substrates 
were purchased from Sigma (St. Louis,MO, USA). The UV asorbances were 
measured on a Cary 100 Bio UV Visable Spectrophotometer from Varian (Palo Alto, 




RP C18 column (5 μm, 4.6 x 250 mm) was from Agilent (Santa Clara, Ca, USA) and 
the Alltima C18 column (5 μm, 4.6 x 250 mm) was from Alltech (Deerfield, Illinois, 
USA). The F-4500 Fluorescence Spectrophotometer was from Hitachi (Tokyo, 
Japan). The VP-ITC Microcalorimeter is from MicroCal (Piscataway, NJ, USA). The 
All other chemicals were of analytical grade. 
6.2 Cloning and Expression of Wild Type and Mutant NAD Synthetases 
 The gene nadE was amplified by polymerase chain reaction (PCR) from 
genomic M. tuberculosis and T. maritima DNA. A 5′ BamHI site and a 3′ HindIII 
sites were engineered into the gene using the following primers: 
nadE from M. tuberculosis  
Forward Primer: 5′d (GGCGGCGGATCCATGAACTTTTACTCCGCC) 3′ 
Tm=52ºC 
Reverse Primer: 5′d (GGTGGTAAGCTTCTAGCCCTTGGGCACC) 3′ Tm=54ºC 
nadE from T. maritima 
Forward Primer: 5′d (GGTGGTGGATCCATGAAAAGACTGAGAGTG) 3′ 
Tm=52ºC 
Reverse Primer: 5′d (GGTGGTAAGCTTTCAAAGAGGTTCTTTAAATC) 3′ 
Tm=52ºC 
The PCR products were digested with restriction enzymes BamHI and HindIII and 
ligated into pSMT3. The ligation reactions were transformed into electrochemically 
competent E. coli DH5α and plated on LB- kanamycin (50 µg/ml). Colonies were 
grown in LB- kanamycin (50 µg/ml) overnight and a plasmid miniprep was 




Quick Change Mutagenesis procedure outlined below unless otherwise noted. The 
primers used were (underlined is the codon mutated and bold is the mutated bases): 
Mutant Y58A 
Forward Primer: 5′d (GACGCTGTCGGGCGCCTCCATCGAGGACG) 3′ 
Tm=79.1ºC 
Reverse Primer: 5′d (CGTCCTCGATGGAGGCGCCCGACAGCGTC) 3′ 
Tm=79.1ºC 
Mutant L486A 
Forward Primer: 5′d (GACCTGTCGGAGGCGGCACTGGGTTGGTCGACATAC) 
3′ Tm=80.9ºC 
Reverse Primer: 5′d (GTATGTCGACCAACCCAGTGCCGCCTCCGACAGGTC) 3′ 
Tm=80.9ºC 
Mutant L486F 
Forward Primer: 5′d (GACCTGTCGGAGTTCGCACTGGGTTGGTCGACATAC) 
3′ Tm=80ºC 
Reverse Primer: 5′d (GTATGTCGACCAACCCAGTGCGAACTCCGACAGGTC) 
3′ Tm=80ºC 
Mutant D656A 
Forward Primer: 5′d (GTTGTCGCCGCGTGGGGCGTGGCGGGCC) 3′ Tm=81ºC 
Reverse Primer: 5′d (GGCCCGCCACGCCCCACGCGGCGACAAC) 3′ Tm=81ºC 
Mutant R658L 





Reverse Primer: 5′d (CATATCCGACGGGGCCAGCCAATCCCCAC) 3′ 
Tm=78.8ºC 
PCR was performed with 0.5 µM primers, 0.5 mM dNTPs and 10 ng/µl nadE/pSMT3 
TB template. The polymerase used was Turbo Pfu. To each reaction 1 µl Dpn1 was 
added and incubated at 37 °C for 8 hrs then 10 µl transformed into electrocompetent 
E. coli Gene Hogs. Colonies were picked and inoculated into LB- kanamycin (50 
µg/ml) and plasmid isolated with Fermentas Mini-Prep Kit. DNA sequencing was 
performed by the University of Maryland Sequencing Facility. 
Plasmids were then transformed into E. coli BL21 (DE3). The transformation 
was performed with 0.5 µl plasmid and 20 µl electrocompetent BL21 (DE3) cells and 
plated on LB- kanamycin (50 µg/ml). One colony was inoculated into 20 mL seed 
culture. Of the seed culture was diluted 200 times into 1 L LB- kanamycin (50 µg/ml) 
and grown at 37 °C to an OD600 of ~0.5. The cultures were then induced with 0.2 % 
lactose and expressed for 48 hrs at 20 °C. The cells were harvested by centrifugation 
and frozen as a pellet in liquid nitrogen (yield ~8 g wet cell per liter culture). 
Selenomethionine labeled protein was expressed in E. coli BL21(DE3) in M9 SeMet 
high-yield media (Medicilon) containing kanamycin (50 mg ml
–1
). The cells were 
induced (at an optical density at 600 nm (OD600) of 0.5) with 1 mM IPTG at 20 ºC, 
harvested by centrifugation 48 h after induction and frozen as a pellet in liquid 








The purification procedure is the same for all enzymes except for the enzyme 
NAD Synthetases
TM
 which does not use glycerol. The approximate yields for each 
step refers to wild type NAD synthetase
TB
. In 50 ml 50 mM Tris pH 8.0, 150 mM 
NaCl, 1 mM DTT and 20% glycerol 5 g cells lysed by French Press (12000 psi, 4 
passes, new nylon ball). The cells were spun at 15000 rpm for 30 mins. The cell free 
extract was loaded on to 8 ml (1 cm X 10 cm) of Ni NTA agrose (Qiagen) resin pre-
equilibrated with 50 mM Tris pH 8.0, 300 mM NaCl, 1 mM DTT, 20% glycerol and 
20 mM imidazole. The column was washed with the 20 mM imidazole buffer for 10 
column volumes (CV) or until the UV absorbance was flat. A gradient from 20 mM 
imidazole to 120 mM imidazole was performed over 10 CV. The column was washed 
with 120 mM imidazole until the absorbance reached baseline then the column was 
washed with 200 mM imidazole. Fractions are collected and ~50 to 60 mg of protein 
is normally obtained at ~1mg/ml concentration (A280 is ~1). For the proteolysis step a 
1 to 100 ratio Ulp1 to tagged enzyme is dialyzed with the enzyme in 50 mM Tris pH 
8.0, 350 mM NaCl, 1 mM DTT and 30 % glycerol for 4 hrs at 4°C. The dialysis 
buffer is then changed to 50 mM Tris pH 8.0, 1 mM DTT and 30% glycerol for 
overnight. The proteolysis reaction is then loaded on to 5 ml (1 cm X 8 cm) Ni NTA 
agrose (Quiagen) resin pre-equilibrated with 50 mM Tris pH 8.0, 300 mM NaCl, 1 
mM DTT and 20% glycerol. The column is washed with the buffer until the UV 
reaches baseline. The concentration of imidazole is then increased to 200 mM to 




concentrated with an Amicon filtration apparatus with Millipore Ultrafiltration 
Membranes 30,000 molecular weight cut off. The protein solution is then dialyzed for 
2 hrs in 50 mM Tris pH 7.5, 1 mM DTT and 30 % glycerol. The protein solution is 
loaded on a 220 ml (2.5 cm X 45 cm) Sepharose CL-6B (Amersham) column in 5 ml 
aliquots and washed with 20 mM Tris pH 7.5, 1 mM DTT, 15% glycerol. The gel 
filtration column was repacked at the beginning of each purification (every other run) 
in order to maintain resolution between the peaks. The fractions are collected and 





± 0.02 wild type NAD synthetase
TB







(Table 6.1). The protein was ~90% pure (Figure 6.1). The extinction coefficient for 
wild type NAD synthetase
TB
 was obtained through amino acid analysis performed by 
University of California (Davis) Molecular Structure Faculty and the extinction 
coefficient for NAD synthetase
TM
 was calculated using the ExPASy ProtParam Tool.  






Enzyme Purification Yield 
NAD synthetase
TB
 4 mg enzyme /g cells 
NAD synthetase
TM
 3 mg enzyme /g cells 
Y58A NAD synthetase
TB
 1.42 mg enzyme /g cells 
L486A NAD synthetase
TB
 2 mg enzyme /g cells 
L486F NAD synthetase
TB
 1.9 mg enzyme /g cells 
R658L NAD synthetase
TB
 1.5 mg enzyme /g cells 
D656A NAD synthetase
TB






Figure 6.1 The protein gels of the mutants of NAD synthetase
TB
. A. The protein 
gel of Y58A, Lane 1 is the ladder, Lane 2 the cells before induction, Lane 3 the cells 
after induction, Lane 4 the cells after lysis, Lane 5 the protein after the first nickel 
column, Lane 6 the protein after proteolysis, Lane 7 the purified protein. B. The 
protein gel of L486F, Lane 1 is the ladder, Lane 2 the cells after lysis, Lane 3 the 
protein after the first nickel column, Lane 4 the protein after the proteolysis, Lane 5 
the purified protein. C. The protein gel of L486A, Lane 1 is the ladder, Lane 2 the 
purified proteins, Lane 3 the protein after the proteolysis, Lane 4 the protein after the 
first nickel column, Lane 5 the cells after lysis, Lane 6 the cells before induction, 
Lane 7 the cells after induction. D. The protein gel of R658L, Lane 1 is the ladder, 
Lane 2 the cells before induction, Lane 3 the cells after induction, Lane 4 the cells 




ladder, Lane 2 the cells before induction, Lane 3 the cells after induction, Lane 4 the 
cells after lysis, Lane 5 the purified protein. 
 
 The MALDI-TOF spectrum of the wild type NAD synthetase
TB
 (Figure 6.1) 
was obtained on a Shimadzu-Kratos Axima-CFR MALDI-TOF mass spectrometer 
(University of Maryland, College Park) in positive-ion mode in the presence of 3,5-
dimethoxy-4-hydroxycinnaminic acid, resulting in a mass of 74,786 ±142 Da 
(expected 74,787 Da). The molecular mass of wild type NAD synthetase
TB
 was 
estimated at 4 ºC by gel-filtration chromatography on a Sepharose CL 6B column 
prequilibrated in 50 mM Tris, pH 7.5, 0.1 M NaCl and calibrated with High 
Molecular Weight Protein Standards (Amersham Biosciences). The successful full 
incorporation of SeMet in the protein was determined by MALDI analysis by the 
School of Pharmacy Mass Spectrometry Facility, University of Maryland, Baltimore 
(Figure 6.2). The UV CD spectra of C176A, D656A, L486A, L486F and wild type 
NAD synthetase
TB
 was acquired from a range of 300 nm to 185 nm at 37 ºC on a 
Jasco J-810 spectrometer. Protein samples were exchanged into 20 mM 
Na2HPO4/NaH2PO4, pH 8.5, using a G-50 spin column. The A280 of all the samples 





Figure 6.2. The MALDI-TOF spectrum of NAD synthetase
TB
. The spectrum 
shows the molecular weight of NAD synthetase
TB
 at 74786 Da and the standard 
bovine serum albumin with a molecular weight of 66319 Da (expected 66382 Da).  
6.4 Protein Crystallization  
Before crystallization, protein samples were thawed and concentrated to 10–
15 mg ml
–1
 using an Amicon Ultra 30 K centrifugal filter device (Millipore). DON-
modified NAD synthetase
TM
 was co-crystallized in the presence of 2 mM DON and 3 
mM NaAD at pH 8.5. Two screening conditions were tested with the sitting drop 
vapor diffusion method (Index and Cryo Suite). Initial screening for crystallization 
were carried out using a Phoenix Liquid Handling System for Crystallography (Art 
Robbins Instruments) with the sitting drop vapor diffusion method in 96-well 
microtiter plates. The sitting drop vapor diffusion method involves two drops and 90 
ml of reservoir volume. One drop contained 0.4 ml of protein solution and 0.4 ml of 




0.2 ml of mother liquor. Crystallization plates were incubated at 20 ºC. Several 
conditions yielded crystals and optimization is ongoing. 
6.5 NAD synthetase Activity Assays 
All activity assays were end-point assays, except where noted and  run at 37 
ºC in 50 mM Tris, pH 8.3, 10 mM MgCl2, 1 mM DTT and 0.3 mg/mL BSA at 
constant ionic strength (adjusted with KCl). Control reactions without the enzyme 
were run in parallel. The pH values of the buffers were measured at the temperature 
of the assays. NAD synthetase was incubated at 37 ºC for 30 mins prior to reaction 
initiation by the addition of substrates (incubated at 37 ºC for 10 mins). Aliquots of 
the NAD synthetase catalyzed reaction were removed at different times and quenched 
in ice with EDTA to a final concentration of 55 mM and then analyzed with one of 
the following assays.  
NAD production. The resulting NAD is reduced to NADH by alcohol dehydrogenase 
in 84 mM Na2HPO4, pH 8.9, with 0.84% ethanol and 0.44% semicarbazide. NADH 




) after 45 minute of 
incubation at room temperature.  
NAD formation can also be monitored by the cycling assay. The cycling assay 
was performed as follows: to 50 µl of the NAD synthetase reaction 100 µl of Solution 
1 was added and incubated at 37°C for 10 mins. The reaction was initiated by the 
addition of 50 µl of Solution 2. Solution 1 contains 75 mM pipes pH 7.0, 100 mM 
lactate, 10 mM KCl and 1 mM WST-8. Solution 2 contains 50 mM pipes pH 7.0, 0.24 
U/µl lactate dehydrogenase and 0.06 U/µl diaphorase. The reaction was incubated at 




0 mins was used as a blank. NAD was quantified by comparison to a standard curve 
(Figure 6.3). The curve was constructed using solutions of NAD at 200, 100, 50 25 
and 12.5 µM. This assay is only performed in the absence of DTT in the NAD 
synthetase reaction. 
 
Figure 6.3 The calibration curve for the cycling assay. All reactions were 
performed in triplicate. 
 Glutamate production. Glutamate concentrations in the time aliquots were 
determined by measuring the absorbance at 340 nm upon reaction with glutamate 
dehydrogenase and by comparison to a standard curve (Figure 6.4). Reaction 
mixtures contained 1.5 mM NAD, 0.05 mM ADP, 0.57 M hydrazine in 50 mM Tris, 
pH 8.0. The reactions were incubated for 45 min at 22 ºC. The presence of the 
hydrazine causes the reactions to have a high background absorbance (~0.2 at 340 
nm) and incubation of the reaction for more than the 1.5 hrs results in a significant 
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Figure 6.4 The calibration curve for the glutaminase assay. All reaction were 
performed in triplicate. 
 
AMP production. Time aliquots from the NAD synthetase catalyzed reactions were 
analyzed on an ion-paired analytical Alltech Alltima C18 column (5 μm, 4.6 x 250 
mm) preequilibrated in 100% solvent A (25 mM KH2PO4, pH 6.4, 4 mM 
tetrabutylammonium bromide, 5% methanol) at a flow rate of 1 mL/min. The various 
compounds, detected at 254 nm, were eluted with a linear gradient from 0-80% 
solvent B (25 mM KH2PO4, pH 6.4, 4 mM tetrabutylammonium bromide, 50% 
methanol) in 27 minutes and hold at 80% solvent B for 10 more minutes. Guanosine 
was used as an internal standard at a concentration of 0.01 mM. The retention times 
for NAD, AMP, NaAD, ATP and guanosine were 13.8 min, 19.5 min, 23.5 min, 28.6 
min and 11 min, respectively. AMP concentration was quantified by comparison with 
a calibration curve (Figure 6.5). The calibration curve was obtained by plotting the 
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of the concentration of the analyte. This assay was used to determine the inhibition 
plots of NADH and to determine AMP formation in the stoichiometry analysis. A 
second HPLC method uses Zorbax Bonus RP C18 column (5 μm, 4.6 x 250 mm) 
preequilibrated in 98% solvent A (100 mM KH2PO4, pH 7.5) at a flow rate of 1 
mL/min. The various compounds, detected at 254 nm, were eluted with a linear 
gradient from 2-10% solvent B (100 mM KH2PO4, pH 7.5, 20% methanol) in 30 
minutes and hold at 10% solvent B for 10 more minutes. The retention times for 
NAD, AMP, NaAD and ATP were 14.9 min, 5.6 min, 10.8 min and 5.4 min, 
respectively. 
 
Figure 6.5 The calibration curve for the ion paired HPLC assay monitoring 
ADP, AMP and NAD formation. Guanosine is used as an internal standard. Each 













y = -0.045165 + 57.393x   R
2
= 0.98357 
y = 0.0079795 + 30.943x   R
2
= 0.99269 







Pyrophosphate/Inorganic Phosphate Assay. After quenching the NAD synthetase 
reaction 8 U/ µl inorganic pyrophosphatase is added. The malachite green assay is 
then performed on the quenched reaction with and without inorganic pyrophosphatase 
addition. The malachite green solution contained 0.12 % malachite green in 2 M 
H2SO4. The solution is stored in the dark. On the day of use 1 part 7.5% ammonium 
molybdate is added to 5 parts malachite green. Then 5 parts NAD synthetase reaction 
is added to 1 part malachite green/ ammonium molybdate solution. The solution is 
incubated at room temperature for 10 mins then the absorbance at 630 measured. The 
calibration curve was prepared with 0 to 20 µM potassium phosphate.  
 
Figure 6.6 The calibration curve for the malachite green assay. All reaction 
performed in triplicate. 
 The phosphate sensor assay was performed on a Perkin Elmer LS55 
Luminescence Spectrophotometer with a plate reader. The excitation wavelength was 
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was 200 µl with 40 µl of phosphate sensor (2.5 µM total concentration). The 
phosphate standards concentrations ranged from 0 to 1 µM.  
6.6 Calculation for Assay Detection Limits 
The detection limit of the alcohol dehydrogenase, NAD cycling and glutamate 
dehydrogenase assays were calculated from a theoretical volume of the NAD 
synthetase reaction of 600 µl total reaction using the maximum possible amount of 
enzyme, 350 µl NAD synthetase at 10 mg/ml concentration. The minimum 
absorbance that would be considered above background for each assay is 0.06 in a 10 
min reaction. 1) The absorbance of 0.06 is used to calculate the moles of product 
utilizing an extinction coefficient or the equation of a calibration curve. 2) The slope 
is obtained for the moles product produced over 10 mins. 3) The slope is then 
multiplied by the dilution factor of the theoretical NAD synthetase reaction (1.7) and 
the dilution factor of the particular coupling assay, the U/ml is obtained. 4) The 
specific activity (U/mg) is then obtained by diving by the concentration of the 
enzyme (10 mg/ml). 5) The turnover per min is obtained by multiplying the specific 
activity by the enzyme molecular weight divided by 1000. 6) The turnover per sec is 
obtained by dividing by 60 sec/min. The sample calculation for the glutamine 
dehydrogenase assay is shown below: 
1) Obtain mmoles glutamate from calibration curve equation (y= -0.012016 + 
4.2436x). 
(0.06-0.012016)/4.2436 = 0.011307 mmols glu/  
2) Obtain slope of mmoles glutamate over 10 mins. 




3) Obtain the activity (U/ml) by multiplying by the dilution factors (2.68 for 
glutamine dyhydrogenase assay and 1.7 for NAD synthetase reaction). 
0.0011307 mM/min*2.68*1.7 = 0.005152 U/ml     
4) Obtain the specific activity (U/mg) by dividing by the enzyme concentration (10 
mg/ml) 
0.005152 U/ml /10 mg/ml = 0.000515 U/mg 
5) Obtain the turnover (min
-1
) by multiplying by the molecular weight of the enzyme.  
0.000515 U/mg*74.6825 mg/mmole = 0.038474 min
-1
 
6) Obtain the turnover (sec
-1
) by dividing by 60 sec/min. 
0.038474 min
-1
 /60 sec/min = 0.00064 sec
-1
 
6.7 Initial Velocity Studies 
The ionic strengths of the glutamine-dependent and ammonia-dependent 
reactions were kept constant with KCl at 0.012 M and 0.1 M (calculated without 
including the MgCl2 concentration that is kept constant in all assays), respectively. 
Initial velocities were measured using the NAD and/or glutamate assays as specified. 
All reactions were performed in triplicate. ATP, NaAD, glutamine and ammonia 
concentrations were, respectively, 4 mM, 3 mM, 20 mM and 100 mM when held 
constant for wild type NAD synthetase
TB
, L486A, L486F, C176A variants and NAD 
synthetase
TM
 catalyzed reactions. In the reaction catalyzed by D656A ATP and NaAD 
concentrations were 8 mM and 6 mM, respectively, when held constant. The 
concentrations for ATP, NaAD, and glutamine when varied in the wild type NAD 
synthetase
TB
, L486A, L486F variants and NAD synthetase
TM
 glutamine-dependent 




concentration of glutamine when varied in the D656A glutamine-dependent reactions 
was 0-50 mM. The concentrations for ATP, NaAD, and NH4Cl when varied in the 
wild type NAD synthetase
TB
, L486A, L486F, C176A variants and NAD synthetase
TM
 
ammonia dependent reactions were 0.5-5 mM, 0.1-6 mM and 1-100 mM, 
respectively. The concentration of NH4Cl when varied in the D656A ammonia-
dependent reactions was 0-1 mM NH4Cl. The ionic strength of the ammonia 
dependent reactions were all adjusted to 0.1 M with KCl. Five different 
concentrations for the varied substrate were chosen in the specified range. All 
reactions were run in triplicate. 
6.8 Temperature Dependent Studies 
The temperature dependence assays for NAD synthetase
TM
 were performed at 
temperatures between 20 °C and 90 °C. The assay was performed under the same 
conditions as the specific activity assay in the presence of either 20 mM glutamine or 
100 mM ammonia. Controls were performed to ensure no degradation of the 
substrates due to high temperatures. A solution of 4 mM ATP and 3 mM NaAD at pH 
8.3 was incubated at 90 °C for 45min and analyzed before and after incubation by 
ion-paired HPLC.  
6.9 Inhibition Studies 
The NAD activity assay was used in these experiments for AMPCPP and the 
ion-paired HPLC assay was used for NADH. Inhibition experiments were carried out 
in a reaction with two of the three substrates at saturating conditions and with varying 




reactions were performed in triplicate. ATP, NaAD and glutamine concentrations 
when held constant were at 4 mM, 3 mM and 20 mM, respectively. The 
concentrations of ATP and NaAD were varied from 0.05 to 4 mM and from 0.02 to 3 
mM, respectively. The concentrations of AMPCPP and NADH were varied from 0 
mM to 2 mM, and from 0 to 1.5 mM (vs. ATP) and from 0 to 0.5 mM (vs. NaAD), 
respectively. The concentration of acetyl-NAD was varied from 0 mM to 2 mM (vs. 
NaAD). 
6.10 Binding Studies 
Fluorescent titration experiments were performed on a F-4500 Fluorescence 
Spectrophotometer (Hitachi). For the intrinsic fluorescence experiments solutions of 
0.5 µM enzyme or 1 µM DON modified enzyme, 50 mM tris pH 8.5, 10 mM MgCl2 
and 1 mM DTT were placed in a 1 cm pathlength cuvette. Ligand was then titrated 
into the cuvette. The excitation wavelength was 295 nm and the emission spectrum 
monitored from 200 to 400 nm. The excitation and emission slit width was 5 nm. The 
fluorescence at the maximum emission wavelength of 337 nm would be plotted 
verses ligand concentration to construct the binding curve. As a control ligand was 
titrated into solution without enzyme to ensure no fluorescence. The concentration of 
the ligands titrated into the solution is as follows 0 to 10 mM ATP, 0 to 50 mM 
ornithine, 0 to 6 mM NaAD and 0 to 30 mM Gln (Figure 2.12). The ligands were 
titrated in to the solution over a period of 30 mins at room temperature. Due to the 
slow basal glutaminase activity at 37 ºC under the conditions of the experiment the 
hydrolysis of glutamine would be negligible. To ensure no reaction the fluorescence 




fluorescence was observed. For the NADH fluorescence experiment a solution of 6 
µM enzyme in 50 mM Tris pH 8.5, 1 mM DTT and 10 mM MgCl2 was titrated with 
NADH (0 to 3 mM). A control without enzyme was also titrated with NADH (Figure 
2.13). The excitation wavelength was 340 nm. The emission spectrum was monitored 
from 300 to 550 nm. The excitation and emission slit width was 5 nm. The difference 
in fluorescence (enzyme solution – control solution) at the maximum emission 
wavelength of 470 nm would be plotted versus ligand concentration to construct the 
binding curve.  
Isothermal titration calorimetry was performed on a VP-ITC Microcalorimeter 
(MicroCal). The sample consists of 50 mM Tris pH 8.3 (at 37 °C), 10 mM MgCl2, 1 
mM DTT, 20 mM Gln and 1.7 µM enzyme previously dialyzed into 50 mM Tris pH 
8.3 and 1 mM DTT. As a control ATP and NaAD were titrated into sample without 
enzyme. The concentrations of ATP and NaAD are 0.04 mM to 1 mM., in the same 
buffer as the enzyme, titrated into the enzyme solution in 10 µl aliquots over 30 
injections while stirring. Data is collected for 200 sec with a 400 sec delay. Under the 
conditions of the experiment the enzyme precipitated possibly due to the removal of 
glycerol. 
6.11 Steady-State Kinetic Analysis 
All data were fitted using the Enzymes Kinetics software package (Systat). Initial 
velocity and competitive inhibition patterns were fitted to eqs. 1 and 2 respectively. 
v/[Eo] = kcatS/[KM + S] 
Equation 6.1 





6.12 Stoichiometry Analysis 
Reactions were run at 37 ºC in 50 mM Tris, pH 8.3, 10 mM MgCl2, 1 mM 
DTT, 0.3 mg/mL BSA at constant ionic strength (0.012 M). The concentration of 
NAD synthetase was 0.23 μM. ATP and NaAD concentrations were 4 mM and 3 
mM, respectively. Stoichiometry analysis was performed on three different reactions 
with 1.5 mM, 5 mM and 20 mM glutamine. The formation of NAD, glutamate and 
AMP was quantified as described above. The channel efficiency is calculated from 
the ratio of the amount of NAD to glutamate formed (Equation 1.1). 
6.13 Glutaminase Effectors 
The glutamate assay with 20 mM L-glutamine was used to determine the 
activation effect of dead-end inhibitors and synthetase substrate on the glutaminase 
domain. The assay was performed in 50 mM Tris pH 8.3, 10 mM MgCl2, 1 mM DTT 
at 37 ºC. When present, the concentrations of ATP, NaAD, AMPCPP, NAD, Acetyl-
NAD, PPi, AMP and intermediate analog 1 were 4 mM, 3 mM, 10 mM, 6 mM, 6 
mM, 2.5 mM, 4 mM and 5 mM respectively. 
6.14 DON Progress Curve 
Progress curves for DON inactivation reactions were generated using the 
alcohol dehydrogenase assay continuously coupled to the NAD synthetase
TB
 reaction. 
We were able to run this assay continuously under saturating concentration of these 
two synthetase substrates because, even though NADH is an inhibitor, it was found to 




assay was performed continuously in 50 mM Tris, pH 8.3, at 37 °C with 4 mM ATP, 
3 mM NaAD, 20 mM glutamine, 10 mM MgCl2, 0.8 % (v/v) ethanol, 0.44 % (w/v) 
semicarbazide, 1 mM DTT, alcohol dehydrogenase and 0-5 mM DON. After 
incubating at 37°C for 30 minutes the solution was initiated with 0.65 μM NAD 
synthetase and followed at 340 nm. Progress curves were fitted to eq. 6.3. The kobs 
values obtained were plotted versus the concentrations of DON and fitted to eq. 6.4 to 
obtain kinact, maximal rate of inactivation, and Ki app, the apparent inhibition constant. 




k = kinact [I]/ KI (1 + [S]/Km + [I]/KI) 
Equation 6.4 
6.15 Inactivation by DON 
The inactivation reaction consisted of 4 mM ATP, 3 mM NaAD, 10 mM 
MgCl2, 1 mM DTT, 20 mM DON and NAD synthetase
TB
. After the reaction was 
incubated at 37°C in 50 mM Tris pH 8.3, for 1.5 hrs, small ligands were removed by 
using Sepharose G-50 (Sigma) spin column. Lack of glutaminase activity in the 
presence of the synthetase substrates confirmed the complete inactivation of the 
enzyme. The enzyme thus modified was tested for its ability to catalyze the ammonia-
dependent formation of NAD in the presence of 100 mM ammonia, 3 mM NaAD and 
4 mM ATP/Mg
2+




6.16 Phylogenetic analysis 
ClustalW was used to align the whole amino acid sequences of 37 glutamine-
dependent NAD synthetases from different organisms obtained from NCBI. The 
sequence of the T. thermophilus used included both the glutaminase and the 
synthetase subunits. The sequence alignment was manually edited with SEAVIEW. A 
phylogenetic tree was constructed using the maximum likelihood method in PHYML. 
Bootstrapping was achieved by constructing 100 trees. The tree was visualized using 
Phylodendron v0.8 (© 1997 by D.G. Gilbert). 
A list of ammonia and glutamine dependent NAD synthetases was provided 
by Andrei Osterman. The 37 genes used for the phylogenetic analysis were chosen 
out of 337 glutamine dependent enzymes which represented organisms from different 
species of bacteria and eukarya. The genes use to construct the tree are as follows: 
Anopheles gambiae, XP_311035.1; Apis mellifera, XP_392994.1; Aquifex aeolicus 
VF5, NP_213654.1; Arabidopsis thaliana, NP_175906.1; Atopobium rimae ATCC 
49626, ZP_03568401.1; Azotobacter vinelandii DJ, YP_002798395.1; Akkermansia 
muciniphila ATCC BAA-835, ACD04457.1; Caenorhabditis elegans, NP_501866.1; 
Clostridium acetobutylicum ATCC 824, NP_348407.1; Clostridium cellulolyticum 
H10, YP_002505537.1; Dehalococcoides ethenogenes, YP_181837.1; Drosophila 
melanogaster, NP_572913.1; Eubacterium siraeum DSM 15702, ZP_02423806.1; 
Fervidobacterium nodosum Rt17-B1, YP_001410277.1; Gallus gallus, 
NP_001006465.1; Gluconacetobacter diazotrophicus PAl 5, YP_001601200.1; 
Herpetosiphon aurantiacus ATCC 23779, YP_001547049.1; Homo sapiens, 




chloromethanicum CM4, YP_002423109.1; Mus musculus, NP_084497.1; 
Mycobacterium bovis AF2122/97, NP_856111.1; Mycobacterium leprae TN, 
NP_302028.1; Mycobacterium tuberculosis C, YP_002079654.1; Thermotoga 
maritima MSB8, NP_229058.1; Ralstonia eutropha H16, YP_725265.1; Rhodobacter 
capsulatus, Q03638.1; Rattus norvegicus, BAC57897.1; Saccharomyces cerevisiae, 
NP_011941.1; Sulfurihydrogenibium sp. YO3AOP1, YP_001930207.1; Sulfurovum 
sp. NBC37-1, YP_001359756.1; Synechococcus elongatus PCC 6301, YP_654197.1; 
Synechocystis sp. PCC 6803, YP_680420.1; Thermodesulfovibrio yellowstonii DSM 
11347, YP_002249082.1;  Thermosipho africanus TCF52B, YP_002335497.1; 
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